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Summary 
Antimicrobial peptides play an integral role in the innate immunity of many plants and 
animals. An essential aspect of the activity of linear antimicrobial peptides is that they are 
cationic and have the ability to form an amphipathic a-helical secondary structure. Blondelle 
et al. identified cationic amphipathic peptides with pronounced antimicrobial activity in 
combinatorial libraries of model 18-residue peptides consisting mostly of Leu and Lys. One of 
these peptides (YKLLKLLLPKLKGLLFKL-NH2) and three N-terminal deletion analogues 
(16-, 14- and 12-residue peptides) were investigated in a structure-function study. Four 
peptide amides were synthesised using the Fmoc-polyamide solid phase peptide synthesis 
protocol. These four peptides were also prepared in immobilised form by an irreversible 
coupling of their carboxy-terminal amino acid to a (0IY)3 linker on an ethylenediamine-
modified polydimethyl-acrylamide resin. The three longer peptide amides (NLK peptides) 
were purified using gel permeation chromatography and the shortest peptide by high 
performance chromatography (HPLC). The high chemical purity of the free peptide amides 
were confirmed by electrospray ionisation mass spectrometry (ES-MS) and analytical HPLC, 
while the integrity of the immobilised peptides were confirmed by amino acid analysis and 
protein sequencing. 
In the structure-function study the influence of peptide length, charge and amphipathicity on 
activity against Micrococcus luleus, Escherichia coli and red blood cells was evaluated. The 
influence of immobilisation on activity was tested against M luteus. The three longer free 
peptide amides had substantial antibacterial activity, but were more active towards the gram-
positive bacterium, M luteus, than towards the gram-negative bacterium, E. coli. This 
specificity could be attributed to the difference in membrane structure of these two organisms, 
with the E. coli membrane differing because of its lipopolysaccharide layer. Interestingly, the 
activity against M luleus was in the same range than against the red blood cells. The 
haemolytic activity of these model peptides thus sOJ;l1ehow correlated with their activity 
against gram-positive organisms. Similar activities were observed for 18-residue and the 16-
residue peptides when tested against the same organism. However, the 16-residue peptide was 
more than five fold less active against E. coli than M lufeus, while the other two peptides 
were about two fold less active. The difference in activity is probably because the 16-residue 
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peptide having one less positive charge than the 18-residue peptide. The 14-residue peptide 
was less active than the two longer peptides, which could be the result of its smaller 
hydrophobic face it has when compared to the longer peptides. The 12-residue peptide amide 
tended to aggregate and was inactive. The reduced peptide length of the 12-residue peptide, its 
aggregation and its smaller hydrophobic face therefore influenced the peptide's activity. Some 
surface activity was, however, observed for the immobilised 12-residue peptide, probably 
because immobilisation prevented aggregation. Similar trends in activity against M luteus 
were observed when comparing the different peptide amides with their immobilised 
analogues, although the immobilised peptides were about 1000 fold less active. 
In conclusion, the amphipathic character, with particular emphasis on the size and density of 
the hydrophobic face, must be maintained to preserve antibacterial activity. Furthermore, 
immobilisation restricted the membrane activity of these peptides to only surface interaction, 
thus limiting any other interaction essential for activity. 
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Opsomming 
Antimikrobiese peptiede speel 'n integrale rol in die aangebore immuniteit van verskeie plante 
en diere. 'n Baie belangrike eienskap vir aktiwiteit van lineere antimikrobiese peptiede is dat 
hulle kationiese moet wees en 'n amfipatiese a-helikse sekondere struktuur moet aanneem. 
Blondelle et al. het kationiese amfipatiese peptiede met verhoogde antimikrobiese aktiwiteit, 
vanuit kombinatoriese biblioteke van model 18-residu peptiede wat meestal uit Leu en Lys 
bestaan, geYdentifiseer. Een van hierdie peptiede (YKLLKLLLPKLKGLLFKL-NH2) en drie 
N-terminaal delesie analoe (16-, 14- en 12-residu peptiede) is in 'n struktuur-funksie 
verwantskap ondersoek. Die vier peptiede is as peptiedamiede gesintetiseer deur gebruik te 
maak van die Fmoc-poliamied soliede-fase peptiedsintese protokol. Die vier peptiede is ook 
voorberei in die geYmmobiliseerde vorm deur hul karboksie-terminale residu onornkeerbaar te 
koppel aan 'n (GlY)3 verlengingsarm op 'n etileendiamien-gemodifiseerde 
polidimetielakrielamied hars. Die drie langer peptiedamiede (NLK-peptiede) is deur middel 
van gelpermeasie c1u-omatografie gesUlwer en die kortste peptied deur middel van hoe 
doeltreffendheid chromatografie (HPLC). Die hoe chemiese suiwerheid van die 
peptiedamiede is deur elektrosproei-ionisasie massaspektrometrie (ES-MS) en analitiese 
HPLC bevestig, terw),l die integriteit van die geYmmobiliseerde peptiede deur aminosuur 
analise en proteien volgorde bepaling bevestig is. 
In die struktuur-funksie studie, is die invloed van peptiedlengte, lading en amfipatisiteit op die 
aktiwiteit teen j\1icrococcus II/feus, Escherichia coli en rooibloed selle ondersoek. Die invloed 
van immobilisering op antimikrobiese aktiwiteit is teen M luteus ondersoek. Die drie langer 
peptiedamiede het beduidende aktiwiteit getoon, maar was meer aktief teen die gram-
positiewe M lute us as teen die gram-negatiewe E. coli. Die spesifisiteit is moontlik as gevolg 
van die verskille in membraanstruktuur tussen die twee organismes, met E. coli wat 'n 
lipopolisakkaried laag het. Wat tog interessant is, is dat die hemolitiese aktiwiteit van hierdie 
model peptiede ooreenkom met hul aktiwiteit teen M luteus. Die 18-residu peptied en die 16-
residue peptied het soortgelyke bioaktiwiteit teen dieselfde teikenselle getoon. Die 16-residu 
peptied is egter vyf maal minder aktief teen M luteus as teen E. coli, terwyl die ander 
peptiede net twee maal minder aktief was. Die verskil in aktiwiteit kan moontlik is moontlik 
as gevolg van die een positiewe lading wat die 16-residu peptied minder het as die 18-residu 
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peptied. Die 14-residu peptied het laer aktiwiteit getoon as die langer peptiede, wat moontlik 
toegeskryf kan word aan die kleiner hidrofobiese kant. Die 12-residu peptiedamied was 
geneig om te aggregeer en het geen aktiwiteit getoon nie. Die verkorte peptiedlengte, 
aggregasie-tendens en die kleiner hidrofobiese kant het dus hierdie peptied se aktiwiteit 
be"invloed. Oppervlakaktiwiteit is weI waargeneem vir die ge"immobiliseerde 12-residu 
peptied, moontlik omdat immobilisering die peptied verhoed om te aggregeer. Soortgelyke 
tendense in aktiwiteit teen M luteus is waargeneem as die peptiedamiede se aktiwiteit met die 
van hul ge"immobiliseerde analoe vergelyk word. Die ge"immobiliseerde peptiede is egter 
omtrent 'n 1000 maal minder aktief. 
Dit is dus belangrik, dat die amfipatiese karakter, spesifiek die grootte en digtheid van die 
hidrofobiese kant, behou moet word om antimikrobise aktiwiteit te bewaar. Verder het die 
immobilisering van die peptiede hulle tot oppervlakaktiwiteit beperk, wat dus enige ander 
interaksie wat nodig is vir aktiwiteit verklein. 
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Preface 
Peptide based host defence can be considered as a pervasive and evolutionarily ancient 
mechanism of immunity. Antimicrobial peptides have been isolated from animals and plants 
and so far several hundred different peptides have been characterised. A variety of peptide 
antibiotics are also found in bacteria. Antimicrobial peptides differ markedly in length, 
sequence and structure, but share two common traits in that they are generally polycationic 
and normally amphipathic. The recognition of the significance of the cationic amphipathic a-
helix has led to de novo design of synthetic antimicrobial peptides that incorporate this 
structural motif. During the years researchers have tried to optimise the activity of 
antimicrobial peptides by changing net charge, peptide length and the size of the hydrophobic 
and hydrophilic faces. Some questions, however, still remain unanswered about the structure-
function relationship of many antimicrobial peptides. Immobilisation of these peptides may 
provide a way to analyse the effect of surface interaction on bioactivity. Immobilisation of 
peptides, that retain antimicrobial activity, may also lead to the development of antimicrobial 
matrixes. 
This thesis describes a structure-function study on model Leu-Lys containing peptides with 
I 
antimicrobial activity. The influence of peptide length, charge, amphipathicity and 
immobilisation on the biological activity of four peptides was tested. We report on the 
syntheses of a model amphipathic a-helical peptide, consisting of I8-residues, and three 
deletion analogues, their purification, characterisation and finally their biological activity. 
First, a short overview of antimicrobial peptides is given in Chapter 1. The synthesis, 
purification and chemical characterisation of the peptides are described in Chapter 2. The 
biological activity of the peptides against Micrococcus [uleus, Escherichia coli and red blood 
cells is described in Chapter 3. In Chapter 4 an integrated overview of the work and future 
prospects are given. 
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Chapter 1 
Biological activity of antimicrobial peptides 
1.1 Introduction 
Vertebrates offer easy access to and a favourable environment for invading parasites and 
potential pathogens. They can penetrate the epithelia of the respiratory and intestinal tracts as 
well as the excretory system. Besides the classical humoral and cellular response of the immune 
system against pathogenic micro-organisms, it is now recognised that vertebrates are endowed 
with an additional chemical defence mechanism involving antimicrobial peptides analogous to 
those found in invet1ebrates [1]. 
Isolation from biological sources such as mammals, amphibians, insects, bacteria and many more 
has served as a common means for discovery of novel antimicrobial peptides such as the 
defensins, magainins, cecropins, gramicidins, bacteriocins and many more [2, 3, 4, 5, 6]. 
Defensins, for example, are sequestered in granules of neutrophils and delivered to phagocytic 
vacuoles containing ingested microorganisms [7]. Frog skins contain glands that produce a large 
number of biologically active peptides, many of which have counterparts in neural and intestinal 
tissues of mammals [8]. One of these peptides, magainin, was discovered in the skin secretions of 
the frog Xenopus {aevis [9]. The cecropins were originally identified as highly potent 
antimicrobial peptides in immune haemolymph from the cecropia moth [10]. It has also been 
found in pig intestine, which implies that cecropins are widespread in the animal kingdom [3]. 
The endogenous antimicrobial peptides of plants and animals are typically cationic (i. e. contain 
excess Lys and Arg residues) amphipathic molecules composed of 12 to 45 amino acid residues. 
These peptides may be produced constitutively or only after infection or injury [11]. The 
antimicrobial peptides are either produced ribosomally (e.g. magainins, defensins, cecropins, and 
many others) or synthesised on enzymatic templates (e.g. gramicidin S, iturin A and others). The 
ribosomally produced peptides can be divided into four main classes [12]: 
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1. Linear peptides without Cys, such as magainin 2 [13] and cecropin A [14]; 
2. Peptides \vith an even number of Cys residues, always linked with disulphide bonds, such as 
the a-and p-defensins [15]; 
3. Linear peptides with a high proportion of one or two amino acids, most often Pro and Arg. 
These peptides do not contain any Cys-residues; examples include indolicidin [16], the 
histatins [17] and the cathelin-derived peptides [18]. 
4. Linear peptides containing unusual amino acids such as the lantibiotics in the bacteriocin 
group of peptides [19]. 
The peptides belonging to the first class often assume an amphipathic a-helical secondary 
structure upon interaction with the outer phospholipid bilayer of a bacterium (e.g. cecropin [10] 
and magainin [9]). On the other hand, the peptides belonging to the second class assume 
antiparallel p-sheet structures e.g. defensins [7]. The peptides in the third class all are part of the 
cathelicidin family [20]. 
Many antimicrobial peptides lyse both gram-positive and gram-negative bacteria (and certain 
types of liposomes), but cause little or no harm to eukaryotic cells (defensins and magainins are 
slightly cytotoxic) [3]. Destruction of the host cells is largely avoided by membrane specificity 
(which will be discussed later in this chapter). In general, their potency (almost like broad-
spectrum antibiotics) and their low cost of production (in terms of time, information, and energy), 
justifies the use of the antimicrobial peptides as a defence mechanism. These factors enable them 
to form an important part of the innate defence of vertebrates against bacterial infections. 
The cationic amphipathic a-helical character of the linear antimicrobial peptides in class 1 was 
shown to play an important role in their biological activity [2, 21, 22]. This recognition of the 
significance of the cationic amphipathic a-helix has led to the de novo design of synthetic 
antimicrobial peptides that incorporate this structural motif. A common approach to the design of 
synthetic antimicrobial peptides has involved the judicious use of hydrophobic and hydrophilic 
amino acids with a high a-helical propensity to generate amphipathic sequences of various 
lengths [23]. During the years researchers have tried to optimise the activity of antimicrobial 
peptides and tried to find out exactly how they work by changing net charge, peptide length and 
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the hydrophobic and hydrophilic faces of the peptides. Some of this work on natural and 
model peptides will be discussed in this chapter. 
l.3 
Researchers believe that the antimicrobial activity is linked to the ability of these amphipathic 
peptides to interact with host cell membranes. The interaction of an antimicrobial peptide with 
membrane lipids and other components also determines its specificity as will be discussed later. 
Upon interaction the formation of ion channels leads to permeability changes and consequent cell 
lysis . Although the exact mechanism of action of antimicrobial peptides is not known, two 
hypotheses will be given. 
1.2 Antimicrobial specificity 
Many antimicrobial peptides selectively inhibit and kill bacteria while maintaining low 
mammalian cell cytotoxicity. This selectivity has been attributed to the differences in the 
membrane structure of mammalian and bacterial cells [24] . The occurrence of some of the most 
common lipidic components in membranes is given in Table 1.1. 
Table 1.1 Lipid composition of some biological membranes [25] 
Percent of total composition in 
Human 
Membrane lipid erythrocyte Human Beefhea11 E. coli cell 
plasma myelin mitochondria membrane 
membrane 
Phosphatidic acid 1.5 0.5 0 0 
Phosphatidylcholine 19 10 39 0 
Phosphatidylethanolamine 18 20 27 65 
Phosphatidylglycerol 0 0 0 18 
Phosphatidy linosi tol 1 1 7 0 
Phospatidylserine 8.0 8.0 0.5 0 
Sphingomyelin 17.5 8.5 0 0 
Glycolipids 10 26 0 0 
Cholesterol 25 26 " 0 .) 
Others 0 0 23 .5 17 
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The outer pat1 of the eukaryotic cell membrane consists mainly of zwitterionic lipids such as 
phosphatidylcholine and sphingomyelin. Phosphatidylcholine is a derivative of glycerol-3-
phosphate while sphingomyelin is a sphingolipid with a cationic choline group attached to a 
phosphorylated hydroxyl group [25]. The prokaryotic membranes consist mainly of 
phosphatidylethanolamine and are rich in negatively charged lipids such as phosphatidylglycerol 
and lipopolysaccharide. Antimicrobial peptides are mostly cationic and would therefore 
preferentially bind to the negatively charged bacterial cells rather than mammalian cells [26, 27]. 
Cholesterol is a weakly amphipathic substance which forms part of the mammalian cell 
membrane and could be another component that influences the selectivity of antimicrobial 
peptides. In addition to cholesterol, both spingomyelin and glycolipids are usually absent from 
prokaryotic membranes [28]. 
Selective activity against prokaryotic orgamsms, also exhibited by some of these peptides, is 
linked to the differences in cell wall structure. Cecropins and magainins are both more active 
against gram-negative bacteria than against gram-positive bacteria [25, 26]. Gram-positive 
bacteria have a thick cell wall with a polysaccharide-peptide complex, know as peptidoglycan, on 
the surface [25]. This peptidoglycan is a heteropolysaccharide. It is composed of amino sugars in 
one dimension and cross-linked through branched polypeptides in the other. The amino sugars 
alternate in the polymer, forming the glycan strands. This results in the bacterium's outer surface 
being negatively charged. Gram-negative bacterial cell walls also contain peptidoglycan, but it is 
single layered and covered by an outer lipid membrane layer [25]. This outer membrane, which 
contains negatively charged lipopolysaccharide molecules, acts as a barrier to hydrophobic 
molecules [24]. 
The interaction of magainins with the outer membrane of Gram-negative bacteria has been well 
studied and it is clear that the peptide has the ability to perturb the structure of the outer 
membrane [26, 29]. Investigations indicate that defensins also permeabilise the outer membrane 
of Escherichia coli. Upon association with the bacterial ilmer membrane, they form channels and 
thereby alter the membrane permeability property [24]. Magainins also exhibit antifungal and 
antiviral activity [29, 30]. Melittin, on the other hand, shows activity against both red blood cells 
and bacteria [31]. 
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Many of the peptides actually lack activity against red blood cells at concentrations at which 
they exert antimicrobial activity [24]. Eukaryotic cells are resistant to lysis, for example, by 
magainins, because of the peptide-cholesterol interactions in their membranes that inhibit the 
formation of lytic peptide complexes. Bacterial cells on the other hand, lacking cholesterol, are 
susceptible to lysis [26]. Another study, with cecropins and related peptides found that sheep 
erythrocytes were highly resistant to lysis; whereas the introduction of D-amino acids, reversed 
sequence or inverted amide bonds did not make the cells significantly more susceptible to the 
peptides [24]. 
Since cecropin, magainin and melittin with D-amino acids exhibit antimicrobial activity identical 
to that of the L-enantiomers, it is unlikely that any chiral recognition is involved at the bacterial 
surface [32]. The specificity in activity could conceivably arise from differences in the 
architecture of the bacterial and red blood cell surfaces. It is likely that the cationic antibacterial 
peptides bind to the sialic acid residues on the red blood cell surface and do not even reach the 
lipid bilayer [24]. In contrast, it was observed that a natural haemolytic a-helical peptide, melittin 
(from bee venom), interacts with the negative charges on the membrane [31]. 
1.3 Model antimicrobial peptides 
As mentioned earlier, the recognition of the significance of a cationic amphipathic a-helix has 
led to the de novo design of synthetic antimicrobial peptides that incorporate this structural motif. 
In these model peptides Leu and Ala are usually used as hydrophobic residues and Lys and Arg 
as hydrophilic residue because of their high a-helical potency [31, 28, 33, 34]. Although the 
length of these a -helical antimicrobial peptides varies considerably, a length of approximately 18 
residues has generally been reported to be necessary to provide an a-helix capable of spanning 
the hydrocarbon portion of the lipid bilayer [35]. 
The model peptides have been used to study the influence of peptide length, charge and the size 
of the hydrophobic face compared to the hydrophilic face on biological activity. The importance 
of the a-helix was also evaluated by a number of investigators. 
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1.3.1 Model peptide design 
Blondelle and Houghten [2] designed synthetic amphipathic peptides (consisting only of Leu and 
Lys residues called LK-peptides) with potent antimicrobial activity. The highest activity was 
found for a 18 residue peptide with the classically amphipathic a-helical sequence, which 
confirmed the role of an amphipathic a-helical conformation on biological activity. When an a-
helix is amphipathic, i.e., one side is hydrophilic and the opposite side is hydrophobic, hydrogen 
bonding within the helix becomes distorted and causes a curvature for the helix. The hydrogen 
bonds formed by the hydrophilic carbonyls with the NH-groups within the helices have been 
found to be longer and less linear than those involving hydrophobic carbonyls [36]. Since Pro 
does not possess a free nitrogen for hydrogen bonding, it was thought earlier that Pro will 
terminate a-helices. It was shown later that if Pro is right in the middle of the helix, it allows the 
continuation of the helix, but with a kink. Pro is the least likely of the amino acids to be present 
in a a-helix; when it occurs, it is found mostly at hydrophilic environments. The kinking is 
always away from the side with the Pro residues [36]. It was found that the inclusion of Pro in the 
middle of the peptide sequence, inducing a kink, sometimes improved activity [37]. 
In a later study, Blondelle et af. [37] used conformational defined combinatory libraries, derived 
from the original I8-residue LK-peptide, to identify compounds with enhanced antimicrobial 
activity. They found four peptides that showed a IO-fold increase in activity relative to the 
original LK-peptide. These peptides contained Pro as \vell as a lie or Phe and Gly in the 
sequence. The peptides showed activity against the Gram-negative bacteria Escherichia coli and 
Pseudomonas aeruginosa, but lower activity against Candida albicans. All four peptides were 
less haemolytic than the original LK-peptide. 
Taking the diversity of natural peptides into account, Tossi et al. [38] compared the first 20 
amino acids of natural occurring peptides, identified the most frequent amino acids in these 
positions and subsequently designed a novel antimicrobial peptide. They found that Gly 
predominates at the N-terminus, acting as a good N-capping residue for the a-helix. Gly is also 
present within the helix for the majority of peptides analysed. In the hydrophobic face, the 
aliphatic, hydrophobic residues dominates, while the hydrophilic face was found to be 
considerably more variable. In their biologically active designed peptides the hydrophobic face 
consisted of contiguous hydrophobic residues, whereas the hydrophilic face consisted of 
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hydrophilic residues interspersed with hydrophobic residues. Lys was the favoured charged 
residue in hydrophilic face. lie and Leu dominated the hydrophobic sector at the N-terminal 
portion of the helix, while Ala was found to be more abundant in the C-terminal portion. Thus, 
they have shO\vn that it is possible to obtain potent, broad-range artificial antimicrobial agents by 
comparing the sequences of naturally peptides and abstracting statistically significant patterns, 
which can be included in relatively short sequences. 
1.3.2 Influence of peptide lengtlt 
For a series of amphipathic peptides, with lengths varying from 8 to 22 residues, the highest 
antimicrobial activities were found for the 14-mer and IS-mer sequences [2]. When compared to 
the much longer magainins and cecropins, the 14-residue sequence had a higher antimicrobial 
activity but a lower haemolytic activity. In another study, IS-residue peptides made up from 
segments of cecropin and melittin were recently found to have higher antimicrobial activity than 
the cecropins [2]. Another group ofLK-peptides (consisting of Leu and Lys (2:1)) with of 15-, 
20-, and 22- residues, showed higher haemolytic activity than melittin. They have a net charge 
and a hydrophobic sector not very different from melittin, despite the fact that there is no 
relationship at all between the sequences or the charge topology. These peptides were found to be 
mainly a-helical in organic and aqueous solvents. In the presence of lipids, a-helicity decreased 
with decreased peptide length [22]. 
Anzai ef (I/. [21] found that short cationic a-helical amphipathic model peptides (8-12 residues in 
length), composed solely of Leu, Arg, and Ala residues, were able to form ion channels in planar 
lipid bilayers [21]. These results were confirmed by McLean ef af. [39] tlrrough the investigation 
of short highly a-helical peptides composed of only Leu and Lys. In this study the peptides were 
compared for their effectiveness in clearing turbid liposomes by examining their interactions with 
phosphatidylcholine. Peptides of 10-12 residues were optimal for the rapid decrease in turbidity 
of liposomes \vhen mixed at the phase transition temperature of the lipids; longer peptides were 
less effective. A peptide of eight residues also formed clear micelles, which demonstrated 
demonstrating that an effective lipid-binding, amphipathic a-helical peptide need only be eight 
residues in length. In another study [28], model peptides were designed using Lys, Leu, Ala and 
Gly and prepared as the C-terminus amides. These peptides were designed to determine the effect 
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of length, sequence, and structure on biological activity. The short peptides (heptamers) were 
inactive against Gram-positive and Gram-negative bacteria when tested. The Leu-containing 21-
mel'S were about twice as potent as the I4-mers [28]. It was proposed that the mechanism of 
action of the shorter I4-mer peptides involve the dimerisation of the peptide, forming a-helixes 
long enough to span the lipidbilayer. 
1.3.3 The hydrophobic/ace vs. the hydrophilic/ace 
Bessalle ef at. [40] showed that the relative proportion between the hydrophobic and basic 
residues of the peptide is very important. In order to achieve high bioactivity in their peptides it, 
was necessary that at least 30-45% of the amino acid residues were basic, the rest being 
hydrophobic. 
The two parameters, namely, hydrophobicity and net positive charge, were investigated by Oren 
el at. [27]. The ratio of Lys and Leu residues was varied to investigate its effect on bio-activity. 
To eliminate the effect of the helical structure D-amino acids and L-amino acids were used. 
Increasing the positive charge drastically reduced the haemolytic activity while the antibacterial 
activity was preserved. Modulating hydrophobicity and positive charge is sufficient to confer 
antibacterial activity and cell selectivity. 
In the work of Blondelle and Houghten [2] an unexpected increase in antimicrobial activity in the 
majority of the omission analogues of LK-peptides was observed. These results indicated that a 
hydrophobic presenting face of five, as compared to a presenting face of nine contiguous 
residues, is sufficient for the peptide to interact with the lipids and/or disrupt the organisation of 
the lipids of the bacterial cell wall [2]. 
Bessalle el al. [40] showed that decreasing the hydrophobic face of an experimental amphiphilic 
peptide decreases its haemolytic activity. In another study, 14- and IS-residue LK-peptides, 
containing a larger hydrophilic than hydrophobic face, were antibacterial whereas a larger 
hydrophobic face resulted in peptides that were more haemolytic [2]. A wider hydrophobic face 
correlated with haemolytic activity, whereas a wider hydrophilic face correlated with 
antimicrobial activity. The omission of any of the hydrophobic residues throughout the sequence 
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of melittin, and particular the omission of any of the Leu residues, dramatically decreased 
haemolytic activity [34]. 
1.9 
Kiyota et al. [41] used five amphiphatic a-helical peptides containing Leu and Lys in different 
ratios to determine the effect of the size of the hydrophobic and hydrophilic faces of the peptide 
on its interaction with lipid- and bio-membranes. Increasing the hydrophobic face area not only 
increased the affinity for lipid, but also increased the trend of self-association. The structure-
activity relationship, estimated by means of ability to cause leakage and haemolytic activity, 
demonstrated that the ability to perturb model- and biomembrane correlates entirely with the area 
of the hydrophobic face [41]. 
Most of these studies mentioned, however, simultaneously examined at least tlu'ee parameters, 
making it difficult to distinguish between the effect of each individual parameter on the overall 
biological activity. Studies using model antimicrobial peptides focused on chain length and 
amino acid composition as well as amphipathic structure. Oh et af. [42], using short «18-
residues) antimicrobial peptides, showed that a high value of some structural parameters (net 
charge, hydrophobicity and a-helicity) is not enough for the best antimicrobial activity, but that 
an optimal balance in structural parameters, particularly amphipathic balance, is required. 
1.4 Mechanism of action 
Magainins, cecropins, defensins and related peptides as well as tachyplesins exe11 their 
antibacterial activity in a manner entirely different [43,44] from the well known antibiotics such 
as the penicillin's and cephalosporins, which interfere with either cell wall or macromolecular 
synthesis in bacteria [45]. The extensive clinical use of these antibiotics resulted in bacterial 
strains developing resistance, causing a serious problem in the treatment of bacterial infections. 
Peptides like magainins exhibit activity against a variety of Gram-positive and Gram-negative 
bacteria in vitro. It also appears to have the ability to augment antibiotic therapy [24]. 
It is now becoming increasingly clear that insects, invertebrates and mammals use peptides to 
counter bacterial infections. Considering the mechanism of action of these peptides it is likely 
that resistance may not develop against peptide antibacterial agents. The observation that the 
biological activity of all D-cecropins and magainins are identical to those of the all L-isomers 
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may help in overcoming the problem of proteolysis that is likely to reduce the half life of the 
all L- peptides in vivo [24]. 
1.10 
The biological activity of amphipathic, a-helical peptides have been thought to result from their 
ability to form ion channels in membrane bilayers [44,43]. Such channels could possibly form by 
self-aggregation of peptide monomers in which the hydrophobic residues interact with the 
phospholipid groups on the cell wall and the hydrophilic residues face inward [31]. The 
observation that cecropins and magainins have amphiphilic helical structures led to investigating 
both their interaction with lipid vesicles and their channel-forming ability by means of 
electrophysical techniques [44]. It was thought that magainins form voltage dependent channels 
in lipid bilayers, but recent research suggests that magainins form pores in membranes [46, 47]. 
Oefensins have the ability to form anion-selective voltage-dependent channels in planar bilayer 
membranes [15]. Cecropins and their synthetic peptide analogues form large time-variant and 
voltage-dependent ion channels in planar lipid membranes at concentrations in the physiological 
range [44]. The ability to form channels in spite of the peptides adopting helical or p-structure 
indicates that channel formation is likely to have an important role in antimicrobial activity [24]. 
The synthetic peptides identified in the study by Blondelle ef al [37] have activities similar to 
peptides isolated from natural sources. It was concluded, using conformational studies, that 
induction into a-helical conformations during interaction with bacterial cell membrane lipids 
and/or sialic acids, promotes the lysis of the cells. The structural constraint induced by this 
peptide-lipid association results in the perturbation of the lipid membrane. This in turn leads 
either to leakage of cell contents or to an initial penetration of the peptides past the membrane 
through hydrophobic interactions between the Leu face of the helix and the phospholipid chains. 
Both of these potential mechanisms result in the death of the cells [37]. 
Oathe el al. [48] used an amphipathic model peptide, KLALKLALKALKAAKLA-NH2 (KLAL-
peptide), to analyse the process of peptide binding to lipid vesicles with different surface charges 
and to determine the structure of the lipid-bound peptides using circular dichroism (CD) 
spectroscopy (Fig 1.1). It was found that charge interactions were the predominant cause of the 
accumulation of cationic KLAL-peptides on the membrane and the disruptive effect of high 
negative surface charge on the bilayers. Independent of any structural propensity, the cationic 
side chains bind to the anionic phosphatidylglycerol moieties. The peptides are held on the 
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bilayer surface by charge interactions, where they may disturb lipid headgroup organisation 
by formation of peptide-lipid clusters [48]. 
1.11 
In contrast, KLAL-peptide-lipid interactions with bilayers that have a low negative surface 
charge are highly dependent on peptide helicity. Less helical peptides exhibit reduced bilayer-
disturbing activity, showing that the hydrophobic helix domain is determines binding to and 
permeabilising membranes with low negative surface charge. It was suggested that hydrophobic 
interactions drive the penetration of the amphiphatic peptide structure into the inner membrane 
region, thus disrupting the arrangement of the lipid acyl chains and causing local disruption [48]. 
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Figure 1.1 Model of interaction of the amphipathic KLAL-helix with lipid bilayers of different 
negative surface charge. (a) Strong electrostatic interactions between the cationic 
residues in the polar face of the helix and the negatively charged lipid head groups 
anchor the peptide in the membrane surface region, preferentially causing changes 
in the organisation of the lipid head groups. (b) At a low negative surface charge 
hydrophobic interactions between the hydrophobic face and the lipid acyl chains 
drives the insertion of the peptide into the ilmer nonpolar membrane region, causing 
a disturbance in the arrangement of the acyl chains [48]. 
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Despite being studied intensely, the precIse mechanism of action of the antimicrobial 
peptides has not yet been elucidated. Two hypotheses on the mechanism of action of the two 
different peptides, cecropin and magainin, are discussed here. 
In Fig. 1.2 the interaction between peptide and membrane is proposed to account for the results 
Christensen ef al. [44] observed in a study using cecropin and related synthetic peptides, is 
depicted. In the Christensen model, also called the barrel-stave model, the first step of interaction 
(step I in Fig 1.2) between cecropin oligomers and the bilayer is electrostatic adsorption to the 
bilayer-water interface. All the positively charged peptides investigated were able to do so. The 
next step (step II in Fig 1.2) could be the insertion of the largely hydrophobic C-terminal region 
into the hydrophobic membrane core, leaving the amphipathic helix in its interfacial position. 
This only happens with those peptides featuring a flexible link (hinge; helix-breaking Gly-Pro 
sequence) between the N-terminal amphipathic helix and the hydrophobic C-terminal segment. 
On the other hand, the molecules with a more rigid chain would not favour this insertion 
mechanism. This may be the reason for their lack of a voltage-dependent conductance. They 
probably insert directly into the membrane to form transmembane channels. The voltage 
sensitivity of cecropins is not due to the amphipathic helix itself but to the special structural 
arrangement between the helix and the more hydrophobic C-terminus. The final step (step III in 
Fig 1.2) of channel formation for peptides having a hinge is favoured by a positive voltage 
(referred to the side of peptide addition) leading to a slow increase of current. This indicates a 
large energy barrier between the closed and the open states of the channel. This step could be the 
insertion of the positively charged amphipathic a-helix in a membrane-spanning configuration 
with the charged residues forming the inner, water-filled pore. The positive charges on the pore 
walls lead to the observed anion preference. The voltage sensing could be because of the 
interaction between the dipole formed from the amino acid backbone of the pre-inserted 
hydrophobic segment with the electric field across the membrane. The voltage sensing is also 
affected by the surface charge and by cholesterol, possibly by means of depth to which the 
segment inserts into the bilayer or by means of the membrane fluidity. Cholesterol changes both 
the fluidity and the dipole potential of bilayers. These observations show that cecropins are potent 
channel-forming peptides under physiological conditions without requiring a specific target 
receptor on the cell membrane. The different sensitivities of bacterial and mammalian cells can 
be explained by the presence of cholesterol in the cell membrane of the latter [44]. 
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Figure 1.2 Tentative model for the interaction of ceropins with a lipid bilayer membrane. Only 
a dimer is sketched for the simplicity, but larger aggregates are likely to occur. 
Refer to text for detail [44]. 
On the other hand, it was shown that magainins form membrane pores rather than channels [46, 
47]. Ludtke et af. [46] proposed a toroidal (or wormhole) model for the magainin pores (shown 
schematically in Fig. 1.3). In this model the lipid bilayer bends back on itself like the inside of a 
torus. This causes the top and bottom mono layers to be continuous. There is an energy cost for 
such a membrane deformation, mainly as a consequence of the bending in the toroidal area. The 
bending can be viewed as a lateral expansion of the head group region relative to the chains. The 
strain of expansion would be reduced by the incorporation of magainin monomers in the head 
group region, thereby stabilising the pore. The length of the peptide would require it to be 
orientated parallel to the pore axis. Since magainin monomers play the role of "filters" to relieve 
the membrane stress, there is probably no peptide-peptide contact, unlike the previously 
mentioned model. 
The action of magainin, as depicted in Fig. l.3 , can be summarised as follows: At low peptide 
concentrations, magainin adsorbs in a primarily helical form parallel to the membrane surface, 
embedded in the head group region. At high concentrations the free energy of surface adsorption 
becomes too high, so that the peptide is driven to an inserted state. Inserted magainin remains 
associated with the head groups. The surface bends in a toroidal fashion to create a pore. Head 
groups and associated magainin monomers line the pore in the toroidal model. When the pore is 
closed, the participating magainin monomers will again adsorb in the head group region, but they 
may surface on either side of the membrane. This type of channel formation also provides a 
mechanism for peptide translocation across the bilayer [46]. 
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Figure 1.3 Toroidal (or wormhole) model of magainin (the cross sectional view). The small 
cylinders represent magainin monomers. The shaded areas represent the head group 
region of the lipid bilayer. Refer to text for more information [47] . 
The carpet mechanism proposed by Oren and Shai [43] describes a situation m which 
amphipathic a-helical peptides initially bind onto the surface of the target membrane and cover 
part of it in a carpet-like maImer. This model is very similar to the toroidial one described earlier. 
The model however proposes that the membrane disintegrates in the final step through 
micell isation. 
1.5 Immobilisation of peptides 
According to all three of the mechanisms discussed earlier (section 1.4) antimicrobial peptides 
must first display some interaction with the target membrane. This surface activity may have also 
lead to some disruption of the membrane function, such as disturbing the membrane fluidity. 
Immobilisation of these peptides may provide a way to analyse the effect of this surface 
interaction on bioactivity. Immobilisation of peptides, that retain antimicrobial activity, may also 
lead to the deve lopment of antimicrobial matrixes . 
Immobilised biomolecules have been exploited m many applications. For example 
immobilisation made it possible to utilise the unique properties of enzymes in analytical 
chemistry, medicine, food and pharmaceutical technology and fine organic synthesis . 
Investigators of enzyme mechanisms have exploited the placement of the catalyst on an insoluble 
support as a means of studying the roles of sub-unit and protein-protein interactions in catalytic 
activity [49). The immobilisation of drugs, hormones, and neurotransmitters on insoluble 
supporting matrices is a technique that has found application in diverse endeavours ranging from 
elucidation of the sites and mechanisms of hormone action to drug receptor isolation and clinical 
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therapeutics [50]. In a study, Kamal el af. [51] found that antibiotic bonding is an efficient, 
safe, and cost-effective method of reducing intravascular catheter infection. 
1.15 
Haynie el af. [52] searched for an experimental design to evaluate the mechanism of action of 
particular antimicrobial peptides. Immobilisation restricts the range of penetration of the 
antimicrobial agent to loci on the surface of the microbial wall. This can be used to test whether 
the antimicrobial peptides are surface active or possibly use another mechanism of action. They 
immobilised a number of peptides on a polydimethylacrylamide resin, generally used for solid 
phase peptide synthesis. The model LK-peptides used in their study were originally identified by 
Blondelle el af. [2]. Magainin, a retro-magainin (reverse sequence) and non-amphiphilic, helical 
peptides were also immobilised in the same manner. Immobilised magainin and some of the Lys-
and Leu-containing model peptides were active, which demonstrated that the outer membrane 
interaction with these peptides is sufficient for lethal activity [52]. As for the non-amphiphilic, 
helical peptides, the immobilised retro-magainin was devoid of activity, implying that the amide 
bond direction and the original N-terminal of magainin and, amphipathicity in general are 
necessary for activity. In another study it was found that the lantibiotic, nisin, only displayed 
antimicrobial activity when it was desorbed from the matrix onto which it had been immobilised 
[53]. 
Antimicrobial peptides such as the magainins, defensins and cecropins may therefore be 
attractive candidates for a support-bound antimicrobial agent because of their broad spectrum 
activities, their relatively lov,r cytotoxicities, and a body of basic evidence that suggest that the 
membrane surface is their lethal site of action. 
1.6 Conclusions 
The discovery of antimicrobial peptides opened a whole new field for antibiotic research. They 
have been isolated from mammals, amphibia and insects, and play an imp0l1ant role in the host 
defence system. All.of the antimicrobial peptides are amphipathic, some are a-helical, and some 
are ~-sheets, \",hile most are cationic in nature. It has been shown that for some peptide sequences 
a peptide length of only eight residues is necessary to give antimicrobial activity [39]. The size of 
the hydrophilic and hydrophobic faces of the amphipathic helix is of great importance. In general 
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peptides with a larger hydrophobic face are more haemolytic than peptides with a larger 
hydrophilic face that have similar antibacterial activity. 
l.16 
All antimicrobial peptides are membrane-active and form channels or pores that cause the cell to 
lyse. Most chalmels, probably formed by peptide aggregates disrupting the membrane, are ion 
selective or voltage dependent. Many mechanisms of action have been proposed (refer to section 
1.4), but it still a major topic under investigation and of contention. 
The mechanism of action is of particular importance in this study in which model antimicrobial 
peptides were immobilised on solid supports. Many different peptides have been immobilised on 
solid supports and on other proteins and successfully used as antigens in immunological studies 
[49]. A problem of the immobilisation of antimicrobial peptides, however, is that it could change 
the antimicrobial activity of the peptides. To overcome this problem, different matrices could be 
utilised to promote activity. Peptide synthesis is now carried out on chitin [54] and cellulose 
paper discs [55]. Furthermore, the solid supports can be functionalised by using different linkage 
agents. Antimicrobial peptides can easily be synthesised and immobilised in the laboratory and 
from structure-activity relationships the best peptide sequence for immobilised activity can be 
identified. 
1. 7 Summary of project and aims 
In this study we decided to use a model peptide with high antimicrobial activity as described by 
BlondeIIe et of. [37] as lead compound. The longest model peptide amide consisted of 18 amino 
acid residues that form an amphipathic a-helix [37]. A helical wheel representation of the 18-
residue peptide can be seen in Fig 1.4. The hydrophobic and hydrophilic faces of the a-helix are 
clearly visible, showing that it is an amphipathic a-helix. 
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Figure 1.4 Helical wheel representation of the longest model peptide used in this study. Blue 
circles show the charged, polar residues, the grey circles the non-polar residues, and 
the green circles show the uncharged polar residues. 
The aims of this study were to: 
• synthesise, purify and analyse the free peptide amides of the I8-residue peptide and three of 
its N-terminal omission analogues; 
• synthesise and analyse the four immobilised peptides, and 
• compare the biological activity of these peptides towards different target cells. 
The immobilised peptides (ll.-K peptides) were synthesised on modified Pepsyn K resin as 
Haynie et al [44] did their study. Three Gly residues functioned as an arm onto which the rest of 
the peptide was synthesised. This linkage arm was included to facilitate the interaction of the 
immobilised peptide with the target cell membrane. 
In Chapter 2 the synthesis, purification and analysis of the peptides will be discussed. The 
structure-function relationship of the peptides will be reported in Chapter 3. Here in particular the 
influence of peptide length, charge, size of the hydrophobic face vs. the hydrophilic face and 
immobilisation on the antimicrobial activity of the four peptides will be addressed. A short 
summary of results and conclusions will then be given in Chapter 4. 
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Chapter 2 
Synthesis and purification of In 0 del cationic a-helical 
peptides 
2.1 Introduction 
2.1 
Studies using synthetic model peptides with antimicrobial activity have been very successful 
in identifying highly active non-toxic peptides [1, 2, 3, 4]. In a single study some of these 
synthetic model peptides were used to investigate the influence of immobilisation on 
antimicrobial activity [5]. These peptides were full-length and N-terminal deletion analogues 
of a I8-residue model peptide containing only Lys and Leu, designed by Blondelle et al. [1]. 
They found that the longer immobilised peptides retained some of their activity against 
bacterial targets [5]. In a later study Blondelle ef al. [4] also identified particularly active 18-
residue peptides using combinatorial defined combinatorial libraries. These peptides showed a 
IO-fold increase in activity when compared to the original peptides and still consisted mostly 
of Leu and Lys. They incorporated Tyr at its N-terminus to allow accurate determination of 
the concentration of these peptides. The peptide, which was chosen for this study, had the 
highest activity against S. aureus and P. aeruginosa when compared to the other peptides. The 
peptide is knovvn to be induced into an amphipathic a-helical conformation in a lipidic 
environment. An opportunity therefore existed for the investigation of the structure-function 
relationship of this model peptide using synthetic analogues, both immobilised and in a 
soluble form. Solid phase synthesis played an integral role in these investigations as it did in 
our study. 
R. B. Merrifield developed solid phase peptide synthesis, and he received the Nobel Prize for 
this work in 1984 [6]. The solid phase approach involves covalent attachment (anchoring) of 
the growing peptide chain to an insoluble polymeric support (resin carrier), so that the 
unreacted, soluble reagents can be removed. 
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Peptide chain elongation is from the C-terminal to the N-terminal. Synthesis in the C~N 
direction leads itself to better chemical control than the N~C direction, where the activation 
of the acyl-amino acids results in optically impure peptides because of racemisation. Peptide 
bond formation in the C~N direction requires the activation of the a-carboxyl group (to 
facilitate bond formation) and reversible protection of the a-amino group of the incoming 
amino acid (to limit polymerisation). 
Many polymers have been tested as an insoluble polymeric support during solid phase peptide 
synthesis, e.g. cellulose, polyvinyl alcohol, polymethacrylate and sulfonated polystyrene [6]. 
Merrifield used is a polystyrene cross-linked with 1 % of m-divinylbenzene, which swells to 
five or six times its volume when treated with the solvents commonly used in peptide 
synthesis, namely dichloromethane and N, N'-dimethylformamide (DMF). The resin support 
is functionalised with chloromethyl groups onto which the first amino acid of the peptide is 
attached. A phenylacetamidomethyl (Pam) handle, which serves to link the first amino acid to 
the resin, was developed to reduce losses during acidolysis. The term handle, is defined as a 
bifunctional spacer with a smoothly cleavable protecting group on the one end, the other end 
coupling to a previously functionalised support [7]. This method of synthesis is based on the 
use of the acid labile tertiary-butyloxycarbonyl (t-Boc) a-amino protecting group and benzyl-
derived side chain protection [8]. 
A nev,l resin, beaded polydimethylacrylamide (polyamide), was developed by E. Atherton and 
R. B. Sheppard. The polar character of this support makes it useful in cases were polystyrene 
is unsuitable [9]. The tBoc amino acid protecting group has been replaced by a 
9-fluorenylmethoxycarbonyl (Fmoc) amino protecting group. This base labile protecting 
group can be removed by secondary amines such as piperidine, eliminating the repetitive acid 
treatments necessary in the tBoc chemistry, and resulting 111 substantially milder reaction 
conditions [8]. 
The polyamide resin was found to be too easily deformed for convenient use in pumped-flow 
equipment. This problem was solved by polymerising the gel resin within a rigid macroporous 
framework, so as to maintain channels for solvent flow, while at the same time allowing rapid 
diffusion of reactants into and out of the physically supported gel. Kieselguhr is a highly 
absorbent material with a pore size many thousands of A in diameter and an accessible pore 
volume about one-third of the total dry volume. Its rigidity, mechanical strength, and large 
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pore size make it a near-ideal carrier for gel res ins . The poly-dimethylacrylamide-Kieselguhr 
resin is manufactured commercially as Pepsyn K and Novasyn K [9, 10, 11]. 
The polyamide gel is formed by copolymerisation of dimethylacrylamide with cross-linking 
and functionalising monomers that provide methyl ester groups as sites for attachment of the 
growing peptide chain to the resin. This support can not be used directly for peptide synthesis: 
it first must undergo derivatisation. Ethylene diamine is used to aminolyse the methyl ester 
and generate amino groups on the resin. orleucine is coupled to act as an internal reference 
standard for amino acid analysis, where after a linkage agent is coupled [9]. The internal 
reference does not form part of the peptide being synthesised and is usually chosen not to be 
amongst its constituent amino acids. That it why the non-protein amino acid, commonly 
norleucine, is convenient [10]. A new concept of individual reversible linkage agents was 
introduced to import additional flexibility to the poly-dimethylacrylamide-Kieselguhr resin. 
Small linker molecules, usually containing a free hydroxyl group, were constructed such that 
the deri vatised esters have stability and liability [10]. A series of benzylalcohol linkage agents 
were made. in which the labi lity of the derived benzyl esters towards acids and nucleophilic 
bases was adj usted by substitution in the aromatic ring . 
..f-hydroxymethylbenzoic acid 
4-hydroxymethylphenoxyacetic acid 
Figure 2. 1 Linkage agents or handles in the Fmoc polyamide peptide synthesis protocol 
[10] . 
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The linkage agent 4-hydroxymethylbenzoic acid is essentially stable even when treated with 
strong acids such as hydrogen fluoride (Fig. 2.1). In contrast, these esters are exceptionally 
easily cleaved by nucleophilic reagents, including hydroxide and ethoxide ions, ammonia, and 
hydrazine. This combination of properties makes this linkage agent highly suitable for the 
preparation of peptide amines. The acid stability allows prior cleavage of all f-butyl 
derivatives (particularly side-chain esters of aspartic and glutamic acids) while the peptide 
remains attached to the resin. The resin with this linkage agent is commercially manufactured 
as Pepsyn KB or Novasyn KB. 
The linkage agent 4-hydroxymethylphenoxyacetic acid is the standard peptide-resin linkage 
agent in the Fmoc-polyamide technique (Fig. 2.1). Peptides linked to the resins through esters 
of this linkage agent can be cleaved by mild acid treatment (usually with trifluoroacetic acid) 
at the same time and under the same conditions used to remove t-butyl side-chain protecting 
groups 10]. The resin with this linkage agent is commercially manufactured as Pepsyn KA or 
Novasyn KA. 
The amino acid with a temporary protecting group, such as tBoc or Fmoc, is then coupled to 
the chemically suitable handle by an ester bond. The tBoc protecting group is removed by 
acidolysis, and the Fmoc by base treatment to liberate the Na-amine of the peptide-resin. The 
next incoming protected amino acid with its suitably activated carboxyl group is introduced 
[7]. After completion of the synthesis the peptide acid or peptide amide can be released by 
acidolysis or base treatment. 
Solid-phase peptide synthesis was also successfully done on chitin by Neugebauer ef al [12]. 
A linker was attached to the chitin and normal Fmoc protocol was used to synthesise the 
peptides. Peptide-chitin complexes formed by peptide synthesis on chitin could prove useful 
for the induction of anti-peptide antibodies. Using chitin is advantageous because of its 
biocompatibility and its availability [12]. Using the Fmoc protocol, peptide synthesis was also 
carried out using cellulose paper discs as segmental solid supports. The rigid structure and 
low swelling properties of the cellulose paper allows the multiple coupling reactions to be 
carried out under low pressure continuous flow conditions [13]. 
The Fmoc-polyamide peptide synthesis methodology (Fig. 2.3) [11] was chosen in this study 
because of its milder chemical approach. The simplicity and elegance of the Fmoc-polyamide 
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chemistry allows the use of only one solvent throughout synthesis and has the additional 
convenience that the Fmoc-group allows UV -monitoring of coupling reactions. 
Syntheses in this study were done with a shake flask method. The solid phase used for the 
synthesis of the immobilised peptide consisted of the polyacrylamide-Kieselguhr resin 
(Pepsyn K), reacted with ethylene diamine onto which the first amino acid of the peptide had 
been coupled. The solid phase used in the soluble peptide synthesis had a 
4-hydroxymethylbenzoic acid linkage agent (Pepsyn KB) to produce the peptide amide when 
cleaved from the resin. The efficiency of the coupling reactions was monitored by a simple 
ninhydrin test, the Kaiser test, [14] or by a Fmoc test [11]. The Kaiser test was used for 
monitoring the disappearance of amino groups during coupling and the appearance of amino 
groups after deblocking. The Fmoc test was used to evaluate the coupling of the previous 
amino acid before the coupling of the next (refer to 2.3.3 for more detail). Amino acid side 
chain protection was provided by t-butyl ester (tBu) and t-butyloxycarbonyl (tBoc) , v,·hich are 
both cleaved under relatively moderate acidic conditions (90% TF A). 
t-b llty l 
CH, 
t-blltyloxycarbonyl I J 
CH3 H3C- C- CH3 I ~ I 
H3C-f-CH31iA ¢o 
O· "/ I TFA 
~ ~=O ~ 1 4-hYdroXYlllethY,Phenoxyacetic acid linker 
o CH, O 0 CH 0 
I I I -II II 1 2 ~ II. 
i O- C- NH- CH- CNHCH2C- NHCH~-0-CH CH2C-o - polydilllethylacrylalll ide o io Kieselguh,· 
N 
~ piperidine 
Figure 2.2 Protection scheme for solid phase synthesis in the Fmoc-polyamide 
methodology . The chemistry is based on mi ld base treatment to remove the N-
terminal Fmoc-group and mild acid treatment to release the free peptide acid [7, 
Figure reproduced with permission from 15]. 
In this study the highly acti ve model peptide from Blondelle et af. [4] and three -deletion 
analogues were synthesised in the so luble amidated forms (NLK peptides) and the 
immobilised forms (ILK peptides) (Table 2.1). Tyvo, four or six of the amino acid residues in 
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the conserved model sequence were omitted from the N-terminal side to form the shorter 
peptides. These shorter peptides were synthesised to investigate the influence of peptide 
length, charge and hydrophilic vs. hydrophobic faces on antimicrobial activity. The peptides 
were amidated to give the same properties to the free peptide as to the immobilised peptides. 
The peptides were immobilised to investigate the influence of immobilisation on the 
antimicrobial activity. Three glycine (Gly) residues were coupled to the resin to form an 
"spacer arm", onto which the rest of the peptide was synthesised. Gly was chosen because of 
its basic structure and ease of coupling. The C-terminal of the ILK peptides was attached to 
this (Glyklinker. 
Table 2. J Primary structure of the cationic a -helical model peptide analogous 
synthesised in this study. (® depicts the Pepsyn K-NH(CH2)2NH-resin) 
Number of Mrof 
Peptide name Peptide primary structure amino acids peptide 
moiety 
ILK 12 LLPKLKGLLFKLGGG-® 12+(GlY)3 1536.98 
ILKI4 KLLLPKLKGLLFKLGGG-® I4+(Gly)} 1778.31 
ILK16 LLKLLLPKLKGLLFKLGGG-® 16+(Gly)} 2004.63 
ILK18 YKLLKLLLPKLKGLLFKLGGG-® 18+(GlY)3 2295 .98 
NLK12 LLPKLKGLLFKL-NH2 12 138l.86 
NLKI4 KLLLPKLKGLLFKL-NH2 14 1623.19 
LK16 LLKLLLPKLKGLLFKL-NH2 16 1849.51 
NLKI8 YKLLKLLLPKLKGLLFKL-NH2 18 2140.86 
The chemical purity of the immobilised peptides was evaluated using amino acid analysis and 
protein sequencing, while the synthesis was monitored by the picric acid test [16] (section 
2.3.3.3), Kaiser test [14] (section 2.3.3 .2) and Fmoc test [11] (section 2.3.3.1). The soluble 
peptide amides were purified using gel permeation chromatography and high performance 
liquid chromatography (HPLC). Chemical purity of the soluble products was evaluated by 
high performance liquid chromatography (HPLC) and electrospray ionisation mass 
spectrometry (ES-MS). 
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2.2 Materials 
2.2.1 General reagents and solvents 
N, N'-dimethylformamide (DMF; 99.5%), ethyl acetate (99.5%), glacial acetic acid (99.8%), 
sodium carbonate (anhydrous), phosphorus-pentoxide, molecular sieve (0.3 A; beads 
approximately 3.2 mm) and self-indicating silica gel were from Saarchem (Krugersdorp, 
South Africa). Chloroform (> 99%), dichloromethane (DCM; 99.5%), dioxane (99.5%), 
diethyl ether (99.5%), ether absolute (99.5%), n-hexane (99.8%), tert-amyla1cohol (> 99%), 
butan-1-01 (99.5%), ethanol (99.8%), piperidine (98%), pyridine (99.5 %), trifluoroacetic acid 
(TF A; > 98% and 99.5%), citric acid I-hydrate (99.5%), magnesium sulphate, potassium 
cyanide (KCN), 2', T-dichlorofluorescein, ninhydrin, I-fluoro-2,4-dinitrobenzene (FDNB), 
aluminium oxide 90 and Kieselgel 60-Fm thin layer plates were from Merck (Darmstadt, 
Germany). Piperidine (99%), pyridine (99.9%) and TF A (> 98%) were also purchased from 
Sigma-Aldrich Chemie (Steinheim, Germany). Dioxane (99.5%), hydrochloric acid (31 %), 
piperidine (98 %) and 2-methylbutan-2-01 were from BDH. High purity dry nitrogen gas was 
provided by Afrox, South Africa. 
2.2.2 Derivatives, cata(l'sts and resins for peptide synthesis 
Pepsyn K-resin (0.1 meg/g), and Pepsyn KB-resin (0.1 meg/g), Fmoc-Gly-OPfp, Fmoc-L-
Leu-OPfp, Fmoc-L-Lys-(tBoc)-OPfp, Fmoc-L-Phe-OH, Fmoc-L-Phe-OPfp, Fmoc-L-Pro-OH, 
Fmoc-L-Pro-OPfp, Fmoc-L-Tyr-(tBu)-OPfp were from Milligen-Millipore (Milford, USA). 
Glycine, Fmoc-L-Leu-OH, Fmoc-L-Lys-(tBoc)-OH, pentafluorophenol, Fmoc-
pentafluorophenol, and N, N'-diisopropylethyl amine (DIPEA) were from Sigma-Aldrich 
Chemie (Steinheim, Germany). Benzotriazol-1-yl-oxy-tris-pyrrolidinophosphonium 
hexafluorophosphate (PYBOP®) was from Calbiochem-Novabiochem Co. (La Jolla, USA). 
N, N'-dicyclohexy1carbodiimide (DCC) and ethylene diamine (99%) were from Merck 
(Darmstadt, Germany). Fluka Chemicals (Buchs, Switzerland) supplied 
I-hydroxybenzotriazole (HOBt). 
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2.2.3 Reagents and solvents for amino acid analysis and chromatography 
Constant boiling hydrochloric acid (HCI, 30%), sodium acetate (99.5%), phenol (99.S%) and 
TF A (99.S%), were from Merck (Darmstadt). Phenylisothiocyanate (PITC) and amino acid 
standards were from Pierce Chemicals (Rockford, USA). Ethylenediaminetetraacetic acid 
tetrasodium salt dihydrate (EDTA, > 98%) was from Fluka Chemicals (Buchs, Switzerland). 
Methanol (HPLC-grade, UV cut-off 20S nm), acetonitrile (HPLC-grade, UV cut-off 190 nm) 
were from Romil LTD (Cambridge, UK). Pico-Tag® sample diluent, Nova-Pak analytical 
HPLC columns, 0.45 micron HV membrane filters were provided by Waters-Millipore 
(Milford, USA). Polygosil (CIS' 60 A, irregular pat1icles) packing material use to prepare 
semi-preparative HPLC column, was supplied by Macherey-Nagel (DUren, Germany). High 
quality triethylamine (TEA) was from Aldrich Chemical Co. (Gillingham, UK). Sephadex 
G 10 and CM-Sepharose were from Pharmacia (Uppsala, Sweden). Analytical grade water was 
prepared by filtering glass distilled water through a Millipore Milli Q® water purification 
system. 
2.2.4 Drying and storage of reagents and products 
Fmoc-amino acids and peptide synthesis resins were stored at 4°C in dessicators with silica 
gel as drying agent. The FDNB was stored at 10°C and the PYBOp® and the HOBt at -20°C, 
both with silica gel (\vith indicator) as drying agent. Before use, amino acid derivatives, 
resins, PYBOp® and HOBt were dried overnight under high vacuum, with phosphorous-
pentoxide as drying agent. The DMF was stored over molecular sieve (0.3 A) at room 
temperature. PITC and amino acid standards were stored at -20°C and TEA (high quality for 
amino acid analysis) at lOoC, all under N2-atmosphere. Peptides were stored at room 
temperature, under vacuum in a dessicator, with silica gel as drying agent. All other reagents 
were stored at room temperature. 
Great care \vas also taken to avoid detergent contamination of glassware, as such 
contamination of the peptide preparations could influence the antimicrobial activity studies. 
The glassware, after the regular washing, was rinsed three times with distilled water, three 
times \vith 60% ethanol and then washed three times with analytical grade water. It was oven-
dried at temperature ranging between 110°C and IS0°C. Bottles for amino acid derivatives 
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and purified peptides, washed in the same way, were also pyrolised at S6S-S70°C for 2 hours 
to remove all traces of contaminating chemicals. 
2.3 Methods 
2.3.1 Preparation of solvents 
2.3.1.1 Distillation ofN, N'-dimethylformamide (DMF) [adapted from 17] 
N, N' -dimethylformamide (DMF) is the main solvent used in the Fmoc-polyamide peptide 
synthesis method. DMF could be contaminated with secondary amines and H20, which 
respectively causes the loss of the Fmoc- and active ester groups. Distilling the DMF removes 
these contaminants. Freshly distilled DMF is therefore used in the synthesis. DMF is kept on 
molecular sieve (3 A) before and after distillation. Impurities, such as volatile secondary 
amines, were removed by fractional distillation under vacuum (high vacuum pump) and a dry 
nitrogen bleed. It was necessary to distil DMF under reduced pressure, because there is some 
decomposition of DMF if distilled at atmospheric pressure. The first 10-IS% of the distillate 
was discarded and the constant boiling fraction (4S0C at 10 mm Hg) was collected. The 
distilled DMF was stored on molecular sieve (3 A) in dark bottles at room temperature and 
used if it passed the Sanger test (section 2.3.1.2). 
2.3.1.2 Sanger's test for secondary amines 
It is necessary to test the DMF for amines, because the Fmoc-group is very labile in the 
presence of secondary amines. Sanger's test [18] was carried out by adding SOO ~lL of each of 
a 1-fluoro-2, 4-dinitrobenzene (FDNB) (1.0 mg/mL in 95% ethanol) and DMF and leaving it 
in the dark and at room temperature for 30 minutes. The absorbance of the reaction mixture 
was determined at 381 nm, with O.S mg FDNB per mL ethanol as blank. The blank's 
absorbance was normally in the region of 0.2 absorbance units, while suitably pure DMF had 
an absorbance at 381 nm of not more than 0.08 units higher than the blank. DMF with an 
absorbance < 0.05 was used for the coupling steps, while the DMF \vith an absorbance 
between O.OS and 0.08 was used for the washing of the resin after deblocking the Fmoc-group. 
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During the synthesis procedure, Sanger's test was used to see if all the piperine had been 
removed after the deblocking step (refer to sections 2.3.3.4.3). The DMF used in the final 
w"ashing steps was tested and an absorbance of less than 0.02 is necessary to proceed onto the 
coupling step. In this case the samples were only incubated for approximately 2-5 minutes. 
2.3.1.3 Distillation of piperidine and pyridine 
Piperidine must be of high purity, for the same reasons as DMF. Piperidine was distilled over 
KOH (10 to 20 gIL) and a dry nitrogen bleed at atmospheric pressure [10]. The first 10-15% 
of the distillate was discarded and the constant boiling fraction (101-1 06°C) was collected. 
The distilled piperidine was stored in dark bottles. Pyridine, for the use in the Kaiser-
ninhydrin test, was also prepared in the same way [10]. 
2.3.1.4 Distillation of diisopropylethyl amine (DIPEA) 
DIPEA must be of high purity, for the same reasons as DMF. DIPEA was distilled from 
ninhydrin (1-2g/l) under a dry nitrogen bleed. The first 10-15% of the distillate was discarded 
and the constant boiling fraction (125-12rC) was collected. The distilled DIPEA was 
aliquotted and stored in dark bottles at 4°C [10]. 
2.3.2 Preparation of amino acid derivatives 
2.3.2.1 Preparation of Fmoe amino acids 
A method described by Carpino. el 01 [19] \-vas used for the synthesis of Fmoc-Gly. To a 
solution of 0.1425 g of glycine dissolved in 5.05 mL of 10% Na2C03 was added, with stirring 
and cooling in an ice bath, a solution of 0.49 g of Fmoc-CI in 3.75 mL of dioxane. The 
mixture was stirred at room temperature for 2 hours, poured into 100 mL of analytical grade 
vvater, and extracted twice with an equal amount of diethylether. This was to remove small 
amounts of 9-fluorenylmethanol and the high-melting polymer of dibenzofulvene. The 
aqueous layer was cooled in an ice bath and acidified with concentrated HCI tot a pH of 2. 
The white precipitate was extracted with 50 mL ethyl acetate, the extracts were washed with 
analytical grade water, dried (MgS04), and evaporated. The white precipitate was dissolved in 
9 mL ethyl acetate, titrated with n-hexane and left at -20oe to crystallise. The melting point of 
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the product was 174°C-175°C and amounted to 0.304 g (54% yield). The melting point 
compared well with that of commercial Fmoc-Gly. 
Thin layer chromatography (TLC) was performed on aluminium backed Kieselguhr 60-F254 
and developed in chloroform:methanol:acetic acid (85: 10:5). Plates were thoroughly air-dried 
and first visualised under UV-light (254 nm). The plates were then sprayed with 0.2% 
ninhydrin in 95% ethanol and developed at 110°C for 10 minutes to detect residual amino 
groups. TLC which showed an UV detectable spot (Rr = 0.55) corresponding to that of 
commercial Fmoc-Gly. 
2.3.3 Synthesis of peptides 
The peptides were synthesised at room temperature using the Fmoc-polyamide protocol in the 
shake flask procedure [15]. The protocol for a complete cycle of operations including 
washing, coupling, deblocking and sampling steps for the Fmoc-polyamide solid phase 
peptide synthesis is set out in Figure 2.3. 
2.3.3.1 The Fmoc test 
To evaluate the coupling of a Fmoc amino acid and specifically the coupling of the first amino 
acid, the UV absorbance character of the liberated Fmoc-fulveen group was exploited [11]. 
To determine the Fmoc-fulveen concentration in a sample, a standard curve was set up with 
Fmoc-Ieucine in 20% piperidine in DMF. A 0.1 mmole concentration of Fmoc-Ieucine was 
treated '''lith 10 mL of 20% piperidine in DMF for 15 minutes to release the Fmoc-group. 
The 20% piperidine in DMF was then removed, diluted a 100 times with DMF, and used to 
make up a dilution series in triplicate. The absorbance of each dilution was read at 290 nm 
and then used to set up a standard curve using DMF as a blank. To evaluate a coupling step, 
10-15 mg of resin was removed, washed with ether, and vacuum dried for one hour. 
The resin was weighed analytically and then deblocked with a volume of 20% piperidine in 
DMF, equivalent to 20 mL per 0.1 mmole expected Fmoc groups. After deblocking, a 100 
times dilution was made of the deblocking mixture, the absorbance measured at 290 nm and 
the percentage coupling calculated from the above equation. 
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I. Swelling of resin 
+ 20 minutes 
+ 4 bed vo lumes of DMF 
2. Anchoring of first amino acid to resin (refer to sections 2.3.3.4.1 ; 2.3.3.5.1) 
+ 2 hours 
+ < 1;2 bed vo lume DMF 
F moc test (refer to section 2.3 .3.1) 
Resin sample A: Kaiser test (ifnot negati ve, repeat coupling) 
Wash resin 6 X 2 bed volume 
3. Removal of Fmoc group (deblocking) with 20% piperidine in DMF (refer to section 2.3.3.4.3) 
+ 30 minutes 
+ 2 bed volumes 
Absorbance at 290nm or Fmoc test (refer to section 2.3.3.1) 
Resin sample B: Kai ser test (if not positive, repeat deblocking) 
Amino acid analysis (post synthesis evaluation) 
2.12 
Wash resin 12 X 2 bed vo lumes until Sanger test is negative (section 2.3.1 .2) 
4. Coupling of next amino acid using ac ti vated Fmoc amino acid (refer to sections 2.3.3.4.2; 2.3.3.5.2) 
+ 60 minutes 
+ <Y2 bed volume 
Resin sample A: Kai ser test (ifnot negati ve, repeat coupling) 
Wash resin 6 X 2 bed vo lume 
5. Repeat steps 3 and 4 for am i no ac ids in seq uence 
6. Removal of side-protection groups and peptide (refer to section 2.3).4.4 ; 2.3.3.5.3) 
7. Washing and drying resin (refer to section 2.3.3.5.3) 
Figure 2.3 Operation of one cycle of the peptide synthesis procedure (bed volume = 5 mUg 
resin). 
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2.3.3.2 Kaiser test for free primary amino groups 
The completeness of the acylation reaction or removal of the Fmoc-group was monitored by 
the Kaiser test [15], which is specific for primary amino groups. Three solutions are required, 
namely (a) 500 mg ninhydrin in 10 mL 95% ethanol, (b) 40 g phenol in 10 mL 95% ethanol 
and (c) 2 ml 0.001 M KCN solution diluted to 100 mL with distilled pyridine. Resin samples 
taken during synthesis were ether-washed and dried, four drops of each of these solutions 
were added to it and heated for 5 to 10 minutes in a 80°-90°C water bath. The presence of 
remaining free amino groups resulted in the resin beads turning characteristically deep blue 
(positive Kaiser test). Alternatively, the reaction solution and resin particles remained yellow 
(negative Kaiser test). Two (or more) samples were taken during each coupling procedure, 
one during the coupling step (sample A at 60 minutes), which should be negative and one 
after the piperidine deblocking step (sample B), which should be positive before continuation. 
If the test did not confirm completion of the reaction, the particular step was repeated or 
reaction time extended. Some of the N-terminal amino acids gave anomalous bead colours 
and not the intense blue of the free amino acid when reacting with the ninhydrin, e.g. proline 
gave a brown colour and serine, asparagine and glutamine a green-orange colour. 
2.3.3.3 Picric Acid Test 
The picric acid test [16] "vas performed on the resin to evaluate the number of amino groups 
available on the peptide resin (Fig. 2.4). The amino resin was reacted with an excess of 
0.05 M picric acid in DMF and the excess reagent removed by thorough washing. Then the 
picrate anion was eluted from the resin with 5 x 5 mL 10% DIPEA in DMF. The resin was 
further washed with DMF between each treatment. When the yellow colour had been removed 
from the resin, the filtrate was made up to a known volume. and measured quantitatively at 
358 nm (the molar absorption coefficient of the picrate is 1.51 x 104 at 358 nm). The results 
show the concentration of the picrate measured as a percentage of the theoretical picrate 
expected. A commercial resin, with Leu attached as first amino acid, was used as positive 
control for 100% amino group saturation. 
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I II 
+ H2NCHC·O-resin ~ 
trinitrophenol 
(p icric acid) 
N0 2 
R RO <f? - + I II ~ I H3N-CHC-O-resin 
N02 N02 
/iPr 
+ excess N -Et 
"'-iPr 
diisopropylethylamine 
R 0 
H3N-6HLo-resin 
diisopropylethylamine picrate 
R 0 
NH26H~-o-resin 
2.14 
Fig1lre 2.,:/ Reaction scheme of picric acid with amino groups on the peptide resin and its 
removal using diisopropielethylamine [16]. 
2.3.3.4 Synthesis of immobilised peptides (ILK peptides) 
The peptides were synthesised at room temperature using the Fmoc-polyamide protocol in the 
shake flask procedure. Four ILK peptides synthesised simultaneously on the same batch of 
Pepsyn K resin. The first 15 residues were coupled, after which a quarter of the resin, 
containing ILK12, was removed. Two more amino acids \-vere coupled to the remaining resin 
and another quarter of the resin, containing ILK14, was then removed. Again two amino acids 
,-,vere coupled to form ILKI6, the resin split in two and the last two amino acids coupled to the 
remaining resin to form ILK 18. 
2.3.3. -1.1 Coupling of the first amino acid 
Pepsyn K resin, with a capacity of 0.1 milli-equivalent per gram of dry resin, was used in the 
synthesis of the immobilised peptides (ILK peptides) . The resin was treated with ethylene 
diamine (lmUg dry resin) for 24 hours to introduce an amino group onto which the first 
amino acid could be irreversibly coupled. The resin was then washed three times each with 
I-amyl alcohol , acetic acid, i-amyl alcohol and ether. The resin was dried by placing it in a 
vacuum desiccator over phosphorus pentoxide. A picric acid test (section 2.3.3.3) was done to 
ensure that all the methyl ester groups on the resin reacted with ethylene diamine. 
Before coupling the first amino acid , the resin was swollen for 50 minutes in high purity DMF 
(20 mUg). The first amino acid was then coupled, using the normal peptide synthesis 
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procedure, to form an irreversible amide bond between the amino acid and the resin. A Kaiser 
test (section 2.3.3.2) and a Fmoc test (section 2.3.3.1) were performed to evaluate whether the 
coupling was complete. 
2.3.3.4.2 Elongation of the peptide chain 
For the elongation steps the required reagent quantities were calculated from the reSll1 
capacity of 0.1 milli-equivalent per gram of dry resin. A three times molar excess of the 
subsequent active Fmoc-amino acids and 1-hydroxybenzotriazol (HOBt) as catalyst was used 
in the elongation of the peptide chain. The pentafluorophenol esters of Fmoc-Gly, Fmoc-L-
Leu, Fmoc-L-Lys(tBoc), Fmoc-L-Phe, Fmoc-L-Pro and Fmoc-L-Tyr(tBu) were used in the 
relevant coupling reactions. The total volume of DMF was limited to < 2 mL/gram of resin in 
the shake flask method. The reaction times of the coupling steps varied from 60 to 90 
minutes, depending on the completeness of acylation, as determined with the Fmoc test 
(section 2.3.3.1) and the Kaiser test (section 2.3.3.2). 
2.3.3.4.3 Removal of the Fmoc-group fi'om the attached amino acid 
After the coupling step was completed (as determined with a negative Kaiser test and a Fmoc 
test), the resin was washed thoroughly to remove any trace of active amino acid derivative and 
catalyst. Piperidine (20% in DMF) was applied to the resin and the deblocking reaction 
proceeded for 30 minutes. The absorbance of the piperidine mixture was measured at 290 nm 
(refer to 2.3.3.1) to confirm the liberation of the Fmoc group. The piperidine was filtered off 
and the resin washed with DMF until the \vash tested negative with the Sanger test (refer to 
2.3.1.2). For a successful synthesis it is imperative that all the piperidine is removed from the 
resin and the reaction glassware. 
2.3.3.4.4 Removal of the side protection groups 
After the final coupling reaction and DMF wash, the resin was washed on a sintered glass 
filter with t-amyl alcohol, acetic acid, t-amyl alcohol and finally with peroxide free diethyl 
ether and then dried under vacuum. The t-butyl groups \vere removed by acid treatment. 
Typically, peptide resin (0.25 g) was treated for 2 hours with 90% trifluoroacetic acid (5 mL) 
containing water (5%) and phenol (5%) as scavengers. The resin was washed again with 
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{-amyl alcohol, acetic acid, (-amyl alcohol and ether. Aftenvards the peptide resin was dried 
by placing it in a vacuum desiccator over phosphorus pentoxide. 
2.3.3.5 Synthesis of soluble peptide amides (NLK peptides) 
A batch-wise procedure similar to the one used for the ILK-peptides was used to synthesise 
the four NLK peptides, removing the first quarter of resin with NLK12 peptide attached (refer 
to 2.3.3.4). The 12 amino acid peptide resulting from this synthesis will be referred to as 
NLK12 1• A second synthesis of NLK12 was done later; this batch will be referred to as 
NLK12 2• 
2.3.3.5.1 Coupling of the first amino acid 
F or the synthesis of the amidated peptides, NLK, the commercially available resin Pepsyn KB 
was used. The resin was swollen for 50 minutes in high purity DMF (20 mUg). The first 
amino acid was coupled to the resin (capacity 0.1 milli-equivalent per gram of dry resin) using 
the PyBOp® method (described hereafter). Coupling efficiency was evaluated with the Fmoc 
test (section 2.3.3.1) and the Kaiser test (see section 2.3.3.2) and the coupling step was 
repeated until the resin was saturated with the Fmoc-amino acid. 
2.3.3.5.2 Elongation of the pep/ide chain 
F or the elongation steps the required reagent quantities were calculated from the reSlll 
capacity (0.1 milli-equivalent per gram of dry resin). A three times molar excess of the 
subsequent active Fmoc-amino acids and 1-hydroxybenzotriazol (HOBt) as catalyst \vas used 
in the elongation of the peptide chain during the first synthesis of the NLK peptides. The 
pentafluorophenol esters of Fmoc-G1y, Fmoc-L-Leu, Fmoc-L-Lys-(tBoc), Fmoc-L-Phe, 
Fmoc-L-Pro and Fmoc-L-Tyr-(tBu) were used in the relevant coupling reactions. For the 
synthesis of NLK122, Fmoc-Gly-OH, Fmoc-L-Leu-OH, Fmoc-L-Lys-OH, Fmoc-L-Phe-OH, 
Fmoc-L-Pro-OH and Fmoc-L-Tyr(tBu)-OH were used after activation by the PyBOB® 
reagent. 
The PyBOB® reagent was used as follows: a three fold molar excess in minimum DMF (0.8-
1.4 mL) of the protected amino acid and HOBt was mixed with the resin. A mixture of three 
fold molar excess PyBOp® and six fold molar excess of N, N' -diisopropylethylamine 
(DIPEA) in minimum DMF (0.8-1.4 mL) \vas then added and mixed thoroughly with the 
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resin. In the shake flask method the total volume of DMF was limited to < 2 mLigram of 
resin. The coupling reaction times varied from 60 to 90 minutes, depending on the 
completeness of acylation, as determined with the Kaiser test and/or the Fmoc test. After the 
coupling step was completed, the Fmoc group was removed as described under section 
2.3.3.4.3. 
2.3.3.5.3 Cleavage from linkage by nllcleophiles: Formation o/peptide amides by aminolysis 
[JO} 
Two different cleavage reactions were used to form free peptide amides. All cleavage 
reactions involving attack by strong nucleophiles on the resin benzyl ester (or of other ester 
linkages) must usually be preceded by removal of the amino terminal Fmoc group, and by 
acidic cleavage of side chain t-butyl derivatives. Fmoc groups can be at least partly removed 
by nucleophilic reagents. 
I. Cleavage with methanolic ammonia 
The I-butyl and tBoc protection groups were removed by treatment of the peptide resin (0.2 g) 
with 90% trifluoroacetic acid (5 mL) containing water (5%) and phenol (5%) for two hours. 
The treated resin was then washed three times with each t-amyl alcohol, acetic acid, t-amyl 
alcohol and diethyl ether and dried by placing it in a vacuum desiccator over phosphorus 
pentoxide. Failure to dry the resin at this stage can lead to the formation of contaminating 
peptide acids. The resin was swollen in DMF, the excess DMF removed by suction and 
transferred to a round-bottomed flask containing approximately 25 mL ice-cold methalonic 
ammonia. The flask was sealed and the resin stirred gently overnight at room temperature. 
After 24 hours the flask was cooled again, opened, and the resin filtered and washed with 
methanol. The combined filtrate was evaporated and the residual peptide amide dried before 
characterisation and purification. The NLK12 J peptide \vas liberated from the resin using this 
method. 
II. Cleavage with liquid ammonia 
Glacial acetic acid (0.4 mL) was added to the peptide resin (1 g) from which the t-butyl and 
tBoc protection groups removed as described in (I). This resin-acetic acid suspension was then 
cooled in a liquid nitrogen bath and dry liquid ammonia (15-20 mL) was added. The high 
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pressure container was sealed, allowed to warm to room temperature and kept overnight. The 
container was then re-cooled, opened, and the ammonia allovved to evaporate. The peptide 
amide was washed from the resin using 50% acetonitrile/water. The combined filtrate was 
evaporated and the residual peptide amide dried before characterisation and purification. The 
four other NLK peptides were liberated from the resins using this method. 
2.3.4 Purification of the soluble peptides (NLK) 
2.3.4.1 Gel permeation chromatography 
A Sephadex G 1 0 gel permeation column (500 mm x 15mm) was used for the purification of 
peptides. Freeze-dried crude peptides were dissolved in 1.5 to 3 mL of a 1 % acetic acid 
solution (depending on solubility). Their absorption at 230 nm and 280 nm was determined 
before being applied to the Sephadex G 10 column and eluted with 1 % acetic acid. Flow rates 
were 10 to 14 mLihour and the eluates were monitored at 230 nm or 280 nm. The major 
absorbing fractions were collected, freeze-dried and analysed for amino acid composition. 
2.3.4.2 Cation exchange chromatography 
A CM-Sepharose column (260 mm x 15mm) was used to further purify the peptide, NLKI2,. 
Before use the column was washed with two bedvolumes 0.45 M ammonium acetate and then 
equilibrated with three bed volumes 0.35 M ammonium acetate (pH 6.0). The freeze-dried 
peptide was dissolved in less than 10% of the bed volume and loaded on the column. Elution 
was initiated with 0.35 M ammonium acetate (pH 6.0) and, after an hour, a linear gradient was 
introduced with 0.45 M ammonium acetate (pH 6.0) as the final concentration. The flow rate 
was 15.6 mLihour and the eluate monitored at 230 nm or 280 nm. Major absorbing fractions 
were pooled, freeze-dried, weighed and analysed for purity by HPLC and ES-MS. 
2.3.4.3 High performance liquid chromatography 
Semi-preparative HPLC was used to purify the NLK121 and further purify NLK12, because of 
difficulties in purifying them sufficiently with gel permeation chromatography and cation 
exchange chromatography. Samples (5 mg/mL) were dissolved in 50% acetonitrile in water 
and centrifuged for 10 minutes at 1000 g to remove undissolved particles. Because of a high 
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tendency to aggregate, samples were freshly prepared just prior to injecting it onto a semi-
preperative C IS Polygosil HPLC column (irregular particle size, 60 A pore size, 250 mm x 10 
mm). The chromatography system consisted of two Waters 510 pumps, MAXIMA software 
control system, Waters Model 440 detector and a WISP 712 sample processor. A linear 
gradient was created using eluant A (0.1 % TF A in water) and eluant B (90% acetonitrile and 
10% eluant A) [16] (Table 2.2). The flow rate was 3.0 mLlmin and the chromatography was 
monitored at 254 nm. The major absorbing fractions were collected, freeze-dried and 
analysed. 
Table 2.2 Gradient program used 111 the high performance liquid chromatography of 
LK121 and NLK122 • 
Time Flow rate 
(min) (mLimin) %A %B 
0.0 ..., 80 20 J 
0.5 ..., 80 20 J 
13 ..., 0 100 J 
14 ..., 0 100 J 
20 ..., 80 20 J 
25 ..., 80 20 J 
2.3.5 Analysis of the immobilised peptides 
2.3.5.1 Protein sequencing 
Protein sequencing was done by means of Edman-degradation [20] , on the Perkin Elmer 
Applied Biosystems Procise 491 Automated protein sequencer, using the pulsed liquid 
method, to confirm the sequence of the ILK peptides. This was done at the Molecular Biology 
Unit at the University of Nata!' 
2.3.5.2 Amino acid analysis 
Amino acid analyses were done using a pre-column derivatisation with phenylisothiocyanate 
(PITC), according to the Pico-Tag® method [21]. Vacuum dried resin samples, taken after 
each coupling, were analysed for amino acid composition after one hour gaseous hydrolysis at 
l50a C. Gaseous phase hydrolysis was done with 6 N HCI containing 1 % phenol under a 
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nitrogen atmosphere. After hydrolysis the acid was removed from the samples under high 
vacuum. In the next step, 20 )lL ethanol:water:TEA (1 :2: 1) was added to each sample to 
ensure a sample pH of 9-10 for derivatisation. The samples were thoroughly vacuum-dried 
before derivatisation \vith 20 ~lL methanol:TEA:water:PITC (7:1:1:1). The derivatisation 
proceeded for 15 minutes at room temperature, before the samples were again vacuum-dried. 
Pico-Tag® diluent (200 )lL) was added to the dried sample. The diluted samples were vortexed 
and filtered through HV 0.45 )lm Millipore membrane filters. 
Chromatography was done at 44°C on the Waters HPLC system, described under section 
2.3.4.3, using a Nova-Pak CIS HPLC column '(150 mm x 3.9 mm). The separation of the 
derivatised amino acids were accomplished with a binary non-linear gradient using eluant A 
(0.14 M sodium acetate, 10 mM EDT A and 0.5 mL TEA per litre water, titrated to pH 6.40 
with acetic acid and then affixed with 6% acetonitrile) and eluant B (60% acetonitrile 
containing 10 mM EDTA) [21]. Pierce standard amino acid mixture (hydrolysis standard) \vas 
used to calibrate the analyses. 
2.3.6 Analysis of the purified soluble peptides 
2.3.6.1 Electrospray mass spectrometry 
Electrospray mass spectrometry (ES-MS) was performed on the NKL peptides, using a 
Micromass Quattro triple quadropole mass spectrometer fitted with an electro spray ionisation 
source. The sample solution (2 ng peptide in 50% acetonitrile/water, 1 O~lL ) was introduced 
into the ES-MS using a Rheodyne injector valve and delivered at a flow rate of 20 ~lLlmin. A 
capillary voltage of 3.5 kV was applied, with the source temperature set at 80°e. The cone 
voltage was set between 60 and 70 V. Data acquisition was in·the positive mode, scanning the 
first analyser (MS I), through m/z = 300-1500 at a scan rate of 100 atomic mass units/second 
(m/z is defined as the molecular mass to charge ratio). Representative scans were produced by 
combining the scans across the elution peak and subtracting the background. 
2.3.6.2 Analytical high performance liquid chromatography 
Reverse phase high performance liquid chromatography (RP-HPLC) was used to analyse the 
purity of the NLK peptide amides. The CIS Nova-Pak HPLC column was used with the 
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system described above for the semi-preparative HPLC in section 2.3.4.3 . The 
chromatography was monitored at 254 nm. A linear gradient was created using eluant A 
(0,1% TF A in water) and eluant B (90% acetonitrile and 10% eluant A). The elution program 
was identical to the one shown in Table 2.2 , except for the flow-rate , which was 1.0 
mL/minute throughout chromatography. 
2.4 Results and discussion 
2.4.1 The Fmoc test standard curve 
The standardisation of the Fmoc test was done by setting up a standard curve using Fmoc-Leu 
and 20% piperidine in DMF. The % Fmoc removed = % coupling of the amino acid. The 
linear relationship (Fig 2.5) between the mmole Fmoc fu lveen and the absorbance at 290nm, 
with curve fit (r1) of 0.9944, was: 
Abs.(290nm) = 0.002848 x % coupling +(-0.009975) 
E 
c 
o 
0.3 
~ 0.2 
-ro 
c 
o 
-a. 
L.. 
o 
II) 
.c 
<l: 
0.1 
0.0 
o 25 75 100 
%Fmoc removed 
Figure 2.5 Curve showing the linear relationship between the percentage Fmoc-fulveen and 
the absorption at 290 1U11, with curve fit (r1) of 0.9944, n=3. 
Values obtained during the Fmoc test that showed 1 00±1 0% coupling, were still sufficient 
because a 10% error could have been made while weighing the resin in preparation of the 
Fmoc test. 
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2.4.2 Synthesis of the immobilised peptides 
The immobilised peptides were successfully synthesised usmg the Fmoc-polyamide 
methodology. Satisfactory Kaiser test results were obtained throughout the peptide synthesis 
(results not shown), which confirmed successful coupling and deblocking steps. The coupling 
time of Leu,s and Lyss was extended to 120 min because the Kaiser test during coupling was 
not satisfactory. The peptides being irreversibly coupled, their analyses were limited to the 
picric acid tests, sequencing and amino acid analysis. Other alternatives, such as solid phase 
NMR and IR teclmiques could have been useded, but they were not readily available. 
2.4.2.1 Fmoc test 
Because the immobilised peptides could not be purified, the Fmoc test was done after each 
coupling to ensure complete coupling, and therefore a pure peptide. The results in Fig 2.4 
show that all Fmoc tests after each coupling step fell within the limit (100±10%) of this 
experiment, except Gly,. The Kaiser test during the coupling of Gly" however, gave a 
negative result, which showed that the coupling was complete. The average coupling 
efficiency (Table 2.3) per step, calculated from the Fmoc tests, were between 98% and 99% 
for each peptide. Thus it can be said that the peptide purity is > 98%. 
C) 
c: 
C. 
~ 
0 
U 
~ 0 
120~--------------------------------~ 
~--------------~--------------
100- r- r- r- r- r- r-
80 
60 
40 
20 
;:.. 1_ r- _ ._ 
GGGLKFLLGKLKPLLLKLLKY 
Amino acid coupling sequence 
Figure 2.6 Summary of the Fmoc tests performed on the peptide resin after each amino acid 
coupling during the synthesis of the ILK peptides. The Fmoc test shows the 
% coupling of each Fmoc amino acid. The 10% error limit to sti ll have 100% 
coupling is indicated by --- . 
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2.4.2.2 Picric acid test 
The picric acid test was performed on the ILK peptides after the removal of the Fmoc and 
tBoc groups from the immobilised peptides. The results show the concentration of the picrate 
measured as a percentage of the theoretical picrate expected (Table 2.3). The control showed 
76% of the expected picrate concentration. Thus, the results were adjusted to compensate for 
the 24% difference. The picric acid test confirmed that the side protection groups were 
successfully removed and showed that the peptide remained on the resin after acidic 
treatment. 
Results confirmed that all Lys-residues were incorporated into these peptides (Table 2.3). 
According to this test, Lys-deletion peptides were limited, as the results of ILK16 showed a 
100% incorporation of this amino acid. However, one of the next coupling reactions to form 
NLK18 (coupling of Lys] and Tyr,), may have been incomplete, because the picric acid test 
revealed only 90% of the expected free amino groups. That the Fmoc test showed a 101 % 
coupling of Lys and 102% of Tyr - may have been the result of experimental error. 
Table 2.3 Summary of the coupling efficiency and the Picric acid test on the ILK peptides. 
The coupling efficienc y was calculated from the Fmoc tests performed on the 
resin after each coupling. The picric acid test shows the number of free amino 
groups on the peptide resin after removal of all the protection groups. 
Number of Expected 
Peptide Coupling Picric acid test number of 
efficiency (%) ( %) free amino 
groups free amino 
groups 
lLK18 99 68 ~.40 6 
ILK16 99 76 5.00 5 
ILK14 98 73 4.80 5 
ILK12 98 74 3.88 4 
Control - 76 1.00 1 
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2.4.3 Analysis of immobilised pep tides 
2.4.3.1 Protein sequencing of the longest resin bound peptide 
Edman-degradation [20] was done on ILK18 by the University of Natal on the Perkin Elmer 
Applied Biosystems Procise 491 Automated protein sequencer, using the pulsed liquid 
method. The degradation was only done on ILK18 , because of the method used to synthesise 
the peptides (refer to section 2.3.3.4). The other three ILK peptides were precursors to ILK18 . 
Results (Table 2.4) confirm the peptide sequence as: 
YKLLKLLLPKLKGLLFKLGGG 
Table 2.-1 Edman sequencing results ofILK18 . Degradation started at the N-terminal of the 
peptide. 
Analysis cycle Retention time (min) pmol Amino acid ID 
I 11.54 40. 16 Tyr (N-term) 
2 19.94 35 .07 Lys 
3 19.15 32.58 Leu 
4 19.15 31.24 Leu 
5 18.97 32.68 Lys 
6 19.17 30.69 Leu 
7 19.17 29.28 Leu 
8 19. 15 28.95 Leu 
9 14.00 16.43 Pro 
10 18.98 14.98 Lys 
II 19.15 16.53 Leu 
12 18.96 19.34 Lys 
13 6.42 14.06 Gly 
14 19.17 18.37 Leu 
15 19. 17 22 .22 Leu 
16 18 .2 15.87 Pile 
17 18.98 15 .24 Lys 
18 19.16 16.04 Leu 
19 6.43 15.28 Gly 
20 6.43 19.90 Gly 
21 6.40 20.64 Gly (C-term) 
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2.4.3.4 Amino Acid Analysis of the resin bound peptides 
The amino acid analysis on the resin sample confirmed that each of the resin bound peptides 
had the correct amino acid composition (Table 2.5). 
The values of Tyr and Pro were lower than expected due to oxidative degradation during 
hydrolysis. Low values for Leu were also observed, probably due to weak hydrolyses because 
of the hydrophobic environment. No correlation could be drawn between the values obtained 
from the amino acid analysis and the Fmoc test. The amino acid analysis did however show 
that the correct amino acids were coupled in the correct sequence. 
2.4.4 Synthesis of the soluble peptides 
The four soluble peptide amides were successfully synthesised using the Fmoc-polyamide 
protocol. Satisfactory Kaiser tests and Fmoc tests were obtained throughout the peptide 
synthesis. The coupling of Leu l8 to the resin was repeated three times to give a satisfactory 
Fmoc test of 93%. The coupling efficiencies of the four peptides from the first synthesis 
varied between 97% and 99%. However, the coupling efficiency of NLK 122 was much lower 
at 95.6% (Table 2.6). 
Methanolic ammonia, one of the cleavage agents, had to be prepared prior to use. It was 
therefore much easier to use the liquid ammonia, which was readily available, as cleavage 
agent for the NLK peptides. The problem with using the liquid ammonia was that the resin 
had to be treated more than once to cleave all the peptide from the resin, but the peptides 
produced by this method was more pure than the ones cleaved with methanolic ammonia. ES-
MS results showed that the peptides had the correct 1'.1" and amino acid sequence (section 
2.4.5.1). 
Analytical HPLC was done on the crude NLK peptides (Figs. 2.7,2.8). The analytical HPLC 
showed more than one fraction with significant UV absorbance. The longest peptide, NLK18, 
had the highest retention time (Rt = 10.04 min) and the shortest peptide, NLK12, the lowest 
(Rt = 9.12 min). NLK16 had a retention time of 9.82 min and the retention time ofNLK14 
was 9.25 min. 
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Figure 2. 7 HPLC chromatograms of crude NLK 18 and NLK 16 using a 150 mm x 3.9 111m 
CI S Nova-Pak co lumn. The linear gradient was developed over 13 minutes with 
0.1 % TF A in water (solvent A) and acetonitrile plus 10% A (solvent B) at a flow 
rate of 1 mLimin. 
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0.1 % TF A in water (solvent A) and acetonitrile plus 10% A (solvent B) at a flow 
rate of 1 mLimin. 
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Figure 2.9 Sephadex G 1 0 chromatography of crude LK18 and NLK 16. The eluant was 
1 % acetic acid in water at a flow rate of 14 mLihour and the bedvolume of the 
column was 85 mL. The absorption values above 1.5 were calculated from 
values determined on dilutions. The bar, I- I , indicatate the peptide-containing 
fractions. 
Stellenbosch University  https://scholar.sun.ac.za
E 
t: 
o 
M 
N 
+-' 
C. 
L. 
o 
CJ) 
.c 
« 
E 
r::::: 
0 
M 
N 
+-' 
nl 
t: 
0 
+-' 
C. 
L.. 
0 
CJ) 
.c 
« 
14 ,------------------------rOA 
12_ 
10_ 
8_ 
6_ 
4_ 
o 
0.90 
0.75 
0.60 
OA5 
0.30 
0.1 5 
0.00 
0 
~K14 
I I 
10 20 
NLK12 
\ 
\ 
I 
-.6. 
30 
I 
40 
I 
50 
I 
60 
I 
70 
elution volume (mL) 
a b 
'a. 
I , 
I , 
, 
, 
, 
\ 
.. 
\ , \ , ~, , 
, ~ .. , , ~ , , , ),., , 
, 
\ .-~-.-.-~-.-"-.'~ '.,. /'\ .... ~ )" 
10 20 30 40 50 60 
elution volume (mL) 
• 230 nm 
.6. 280 nm 
I 
80 
• 
.6. 
70 
I 
90 
_0 .3 
rO .2 
rO .1 
0.16 
230 nm 
257 nm 
0.1 2 
0.08 
0.04 
0.00 
80 90 
2.30 
» 
C'" 
CJ) 
o 
.., 
""C ,.... 
» 
C'" 
CJ) 
0 
.., 
""C ,.... 
0 
:::::s 
Q) 
,.... 
I'\,) 
01 
...... 
:::::s 
3 
Figure 2.10 Sephadex 010 c1u'omatogaphy of crude NLK14 and NLK12, . The eluant was 
1 % acetic acid in water at a flow rate of 14 mLihour and the bedvolume of the 
column was 85 mL. The absorption values above 1.5 were calculated from 
values determined on dilutions. The bar, I-I , indicate the peptide-containing 
fractions. 
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The purity of the crude peptide amides, NLK 122, NLK 14, NLK 16 and NLK 18, as determined 
by ES-MS (section 2.4.5.1), was already high with very little contaminating peptide material. 
The NLK121 peptide, on the other hand, had contaminating material because of the different 
procedure used to remove the peptide from the resin. During the use of the methanolic 
ammonia, methylesters formed. These peptides could not be separated from the amidated 
peptides and consequently it was necessary to purify NKL 121 further to ensure higher purity. 
The other peptides were also further purified, as impurities can influence bioactivity results. 
2.4.4.1 Purification of soluble peptide amides 
The crude NLK12 I , NLK14, NLK16 and NLK18 were chromatographed on a Sephadex GI0 
to remove low molecular mass impurities (Figs. 2.9, 2.10). Satisfactory separations were 
obtained and the major absorbing fractions, containing the peptide material, were pooled and 
freeze-dried. 
The NLK 121 was further purified using chromatography with Sepharose cation exchange 
(results not shown). ES-MS analysis showed that contaminating peptide material still 
remained in the preparation (results not shown). Thus, the methylesters could not be separated 
from the ami dated peptides by cation exchange chromatography. After cation exchange 
chromatography the fractions containing the peptide material were purified using semi-
preperative HPLC. The second synthesis product (NLK122) was directly purified using semi-
preparative HPLC. 
The HPLC purification of NLK12 was successful, when eluting the fractions with the linear 
gradient program depicted in Table 2.2. In the case of NLK12 I , five peptide fractions were 
collected, and in the case of NLK122 four peptide fractions were collected (Fig. 2.11) and 
evaluated by ES-MS to determine which fraction contained the pure NLK12 peptide (results 
not shown). 
Peptide yields were satisfactory (Table 2.6), although higher yields were expected. After the 
removal of the peptides from the resins, amino acid analysis was done on the resins (results 
not shown). The amino acid analysis showed that there remained peptide on the resin after 
cleavage and therefore picric acid tests were done to determine the amount of peptide on the 
resin (Table 2.6). Results from the picric acid tests confirmed amino acid analysis data and 
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Figure 2.11 HPLC chromatograms of the crude NLK12 peptides (NLK121 and NLKI22) 
using a 250mm x 8 mm C 18 Polygosil column. The linear gradient was 
developed over 13 minutes with 0.1 % TF A in water as solvent A and 
acetonitrile plus 10% A as solvent B at a flow rate of 3mLlmin. Fractions that 
contained the peptide (as evaluated by ES-MS) are indicated by ( I-I) on the 
chromatograms. 
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offered an explanation for the low crude peptide yield, namely incomplete cleavage of the 
peptides from the resins. Another reason for the low purified peptide yield was the high 
tendency of the LK peptides to form insoluble aggregates. The best cleavage was obtained 
with the methanolic ammonia protocol, but extensive losses occurred because of the formation 
of peptide methyl esters (refer to Fig. 2.16). Large amounts ofNKL18 and KL122 remained 
on the resins and could still be retrieved by repeating the cleavage procedure. 
Table 2.6 Summary of peptide yields and coupling efficiency obtained for the synthesis of 
the four peptide amides. 
Peptide % Peptide left % Crude yield 2 % Purified % Coupling 
on the resin' yield 3 efficiency ~ 
LK18 27 43.8 62.5 97.0 
LK16 14 69.1 20.6* 98.5 
NLK14 7 75.3 46.2 98.4 
NLKI2, 4 71.8 49.8 98.4 
NLK122 24 45.5 44.2 95.6 
i % peptide left on the resin was calculated from the picric acid tests on the resin samples after cleavage 
C % crude yields = 100 x analytically weighed dry crude peptide preparation/expected yield from resin 
.1 % purified yield = 100 x amount purified peptide from column/amount crude peptide loaded on column 
-l % coupling efficiency = 100 x corrected crude yield i/nul11ber of residues (% crude yields were corrected for cleavage 
efficiency) 
* Some of the crude NLK 16 was lost during preparation for G I 0 chromatography 
2.4.5 Analysis of the soluble peptide amides 
2.4.5.1 Electrospray mass spectrometry of the peptide amides 
Before discussing the ES-MS analysis of each peptide, a short background on the 
fragmentation of peptides during mass spectrometry is given. Fragmentation of peptides in 
ES-MS generally occurs at the peptide (amide) bonds (b and y product ions), but some other 
ion types from backbone fragmentation also occur. The nomenclature of Roepstorff and 
Fohlmann [22] , as revised by Biemann and Martin [23] , was used to identify the product ions 
from fragmentation of peptide molecular ions (Fig. 2.12) 
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Figure 2.12 Fragmentation patterns of a peptide during mass spectrometry and nomenclature 
according to Roepstorff and Fohlmann [22] , as revised by Biemann and Martin 
[23]. [Figure reproduced with permission from 15]. 
The fragment or product ions can be separated into two classes (i) a,p bn, and Cn product ions 
from the -terminal, and (ii) Xn, Yn and Zn product ions from the C-terminal (Fig. 2.12). The 
subscript n indicates the number of amino acid residues in fragment. Because fragmentation 
at the peptide bond is predominant, the peptide sequence can be deduced or confirmed by the 
formation of certain product ions. 
The correct 111/Z (molecular mass/charge ratio) was found for each of the purified NLK 
peptides (Figs. 2.13-2.17). For LK18 (Fig. 2.13) the COlTect m/z of 1071 for the doubly 
[M+2Hf- charged peptide was observed with y"5 (111/Z 631.5) as the major product ion, 
confirming its sequence. The COlTect m/z of 715 was observed for the triply charged peptide 
ion [M+3H]3+ and m/z of 536 for the quadruply charged peptide ion [M+4H]~~ . Various 
contaminants were removed during purification; refer to Fig 2.13 for comparison. 
For NLK16 (Fig. 2.14) the correct 111/Z of the multiply charged molecular ions [M+2Hf~ (m/z 
925), [M+ 3H]3- (111/Z 617) and [M+4H]4- (111/Z 463) were observed. The major product ions 
were the triply charged y" , ~ (111/Z 542) and the triply charged dehydrated peptide ion (171/Z 612), 
which confirmed the peptide sequence. Various contaminants were removed during 
purification; refer to Fig 2.14 for comparison. 
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Figure 2.13 ES-MS spectra of the crude (A) and purified (B) NLK 18. Analysis conditions 
are described under 2.3.6. 1. Contaminants removed during purification are 
indicated by *. 
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Figure 2.1-1 ES-MS spectra of the crude (A) and purified (B) NLK16. Analysis conditions 
are described under 2.3.6. 1. Contaminants removed during purification are 
indicated by *. 
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Figure 2. J 5 ES-MS spectra of the crude (A) and purified (B) NLK14. Analysis conditions 
are described under 2.3.6.1. Contaminants removed during purification are 
indicated by *. 
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Figure 2.16 ES-MS spectra of the crude (A), and HPLC purified (B) NLK12 j • Analysis 
conditions are described under 2.3.6.l. Contaminants removed during 
purification are indicated by *. 
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The correct 111/Z of 812 for the doubly [M+2Hf+ charged peptide ions, and 542 for the triple 
charged peptide ions [M+3H]3+ ofNLK14 were observed (Fig. 2.15). The major product ions, 
as (/11/z 536) and alO (1I1/Z 1077) confirmed the peptide sequence. The doubly charged product 
ion, bl) was also observed with a 111/Z of 748. Various contaminants were removed during 
purification; refcr to Fig 2.15 for comparison. 
Peptide NLK12 (Figs. 2.16, 2.17) fragmented extensively under the ES-MS conditions used in 
the analysis. The correct 111/Z (1382.1) ofNLK12 was observed, as well as the major product 
ions, a1 (mlz 198.6), b7 (111/Z 749) and Y"7 (111/Z 817), confirming its sequence. MUltiple charged 
peptide ions were observed ([M+3Hf+ 111/Z 461; [M+2Hf+ 111/Z 691) as well as the triply and 
doubly charged fragment, Y"IO (111/Z 386 and 111/Z 578). Various contaminants were removed 
during purification; refer to Figs 2.16 and 2.17 for comparison. The major contaminant 
([M+2H]2+ 111/Z 699) in NLK121 was the methyl ester formed by the methanolic ammoma 
which was used to remove the peptide from the resin. 
2.4.5.2 Analytical HPLC of the peptide amides 
Analytical HPLC was done on the purified peptides, but satisfactory results could not be 
obtained. This was attributed to the fact that the NLK peptides have a high tendency to 
aggregate. This aggregation was observed in the analytical HPLC chromatograms. It seems as 
if the contaminating material in the crude prevents the peptide from aggregating, because the 
aggregation was not observed in the HPLC of the crude peptides. In Fig. 2.18 the analytical 
HPLC profile of the purified NKL12 changed dramatically (refer to Fig. 2.8), with most of the 
absorbing peptide fraction eluting in the void volume of the column. Similar results were 
obtained for the other peptides (results not shown). 
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Figure 2.18 Analytical HPLC chromatogram of purified NLK 12. 
2.5 Conclusions 
The shake flask solid phase peptide synthesis, based of the Fmoc-polyamide methodology, 
was successfully employed to synthesise both the immobi lised and the free peptide amides. 
Amino acid analysis, ES-MS and protein sequencing unambiguously confirmed that the 
correct peptides had been synthesised. The immobilised peptides could not be removed from 
the resin, and therefore it could not be purified in any way. Immobilised peptides of high 
purity were obtained because special care was taken during the synthesis. Analysis of the free 
peptide amides was laborious because purified peptides tended to self-aggregate . 
Two different methods were used in cleaving the peptides from the resin to form peptide 
amides. For the first peptide cleaved of the resin, methanolic ammonia was used, but for the 
others the easier method, using liquid anm10nia, was used. With the use of the methanolic 
ammonia, methyl-esters were formed, contaminating the ami dated peptide. This necessitated 
consequently labourious purification to obtain the dodecapeptide amide product. The use of 
liquid ammonia, however, gave a lower crude peptide yield because some of the peptide still 
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remained on the resin. More than one treatment with liquid ammonia was thus necessary, but 
the purification of the peptides was much easier. 
The shorter peptides tended to self-aggregate more than the longer ones. Aggregation \vas 
especially observed with NLKI2, which lead to diminished biological activity (discussed in 
Chapter 3). The differences in aggregation must have been due to the peptide structure, which 
changed the net charge and amphipathicity of the peptides. The next chapter describes our 
investigation of the influence of peptide length, charge, amphipathicity and immobilisation on 
the biological activity of the peptides. 
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Chapter 3 
The influence of structure and immobilisation on the 
antimicrobial activity of model a-helical peptides 
3.1 Introduction 
3.1 
Many of the natural antimicrobial peptides that have been isolated assume a umque 
amphiphilic secondary structure upon interaction with the outer phospholipid bilayer of a 
bacterium. This characteristic may be induced by an a-helical, e.g. cecropin and magainin, or 
a p-sheet, e.g. defensin, molecular organisation of the peptide in hydrophobic media [1]. 
Blondelle ef al. [2] designed synthetic amphipathic peptides (consisting of Leu and Lys) with 
potent antimicrobial activity. The highest activity was found for peptides with an amphipathic 
a-helical structure, which confirmed the role of an amphipathic a-helical conformation in 
biological activity of these peptides. 
Cornut el al. [3] concluded that longer peptides, consisting of Leu and Lys (LK-peptides), 
have a more stable a-helical structure than shorter ones. The influence of peptide length has 
been the subject of many investigations. Anzai ef al. [4] found that short cationic a-helical 
peptides (8-12 residues in length), composed solely of Leu, Arg, and Ala, were able to form 
ion channels. McLean ef al. [5] demonstrated through a study with short highly a-helical 
peptides, composed of Glu, Leu and Lys, that an effective lipid-binding, amphipathic, 
a-helical peptide need only be eight residues in length. The haemolytic activity of 12 to 22-
residue long LK-peptides could, on the other hand, not be correlated with peptide length [3]. 
It seems as if peptide length has a little influence on activity, and thus the influence of 
amphipathicity of the peptides was also investigated. 
Not all amphipathic a-helical peptides have antimicrobial or cytotoxic activity. For example, 
peptides in the AI, A2 and Y classes of a-helices also interact with membranes without 
disrupting membrane function [6]. The a-helical antimicrobial peptides, however, have a 
markedly different sequential distribution of polar and non-polar amino acids leading to 
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amphipathic helices of the L-class or lytic class [7]. The importance of amphipathicity 
(i.e., the different presenting faces of the peptide) on biological activity of LK-peptides was 
evaluated by Blondelle et al. [2]. A large number of contiguous hydrophobic residues in an 
amphipathic peptide appear to be necessary for significant haemolysis to occur. An increase 
in antimicrobial activity was observed in the majority of the omission analogues. This 
suggested that a hydrophobic face of five contiguous residues as compared to a presenting 
face of nine contiguous residues is sufficient for the peptide to interact with the lipids and/or 
disrupt the organisation of the lipids of the bacterial cell wall. Bessalle et al. [1] confirmed 
that peptides that were very hydrophobic showed higher cytotoxicity. They postulated that the 
relative proportion between the hydrophobic and basic character of the peptide is important. 
Their model peptides showed that in order to achieve high bioactivity, 30-45% of the amino 
acid residues should be basic, whereas the rest can be hydrophobic. One of the highly basic 
peptides (0:::; 60% basic residues) did not have antimicrobial activity. 
The environment in which these peptides are presented to the target cell membrane also 
influences biological activity of these membrane-active peptides. Limiting the interaction of 
these peptides with its target membrane by immobilisation could lead to lower activity. It is, 
however, possible that some antimicrobial peptides may be suitable candidates for 
immobilisation because of their activity. Matrices with antimicrobial activity find application 
in industrial filter systems as well as in medicine. Microbial contamination and possible 
infection of the host are major concerns in the area of therapeutic medical devices and 
therefore new approaches are devised to avoid microbial contamination. Sequestering the 
antimicrobial agent close to the device surface has shown to be an effective approach in 
reducing the potential for catheter-related infections in patients [8]. 
Haynie et al. [9] investigated the antimicrobial activities of amphipathic a-helical peptides 
that were covalently bonded to a water-insoluble resin. They suggested that the surface action 
by magainins and structurally related antimicrobial peptides are sufficient for their lethal 
activities. No activity was, however, observed for either an immobilised peptide whose amino 
acid sequence was the exact reverse of that of magainin 2 or for several non-amphipathic, 
helical peptides. Amphipathic a-helical peptides with as little as seven residues still showed 
antimicrobial activity at high concentrations. Peptide length seems to play a role in the 
activity of these immobilised peptides, but it is not the major contributing factor for showing 
antimicrobial activity. In the activity of such peptides, immobilisation, however, restricts the 
range of penetration of the antimicrobial agent to loci at .the surface of the microbial Viall. 
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Immobilising the peptide is an easy way to test the extent surface activity of antimicrobial 
peptides and can also be used as a tool to probe mechanism of action and structure-function 
relationships. 
The main aim of this study was to investigate the structure-function relationship of a model 
antimicrobial peptide, especially with regard to the influence of peptide length, charge, 
hydrophilic versus hydrophobic faces and immobilisation on the antimicrobial activity was 
investigated. 
Using combinatorial libraries, Blondelle et al. [10] identified I8-residue peptides with a 10-
fold increase in activity as compared to the original peptides. These peptides are known to be 
induced into an a-helical conformation in a lipidic environment. One of these 18-residue 
peptide amides, YKLKLLKLLLPKLKGLLFKL-NH2, and three N-terminal deletion 
analogues were synthesised in both the free peptide amide and irreversibly immobilised form 
(refer to Chapter 2; Table 3.1). 
Using the same water-insoluble resin, polydiacrylamide in Kieselguhr (Pepsyn K) as Haynie 
et al. [7], \ve tested the influence of immobilisation on the antimicrobial activity of these 
peptides. Three Gly-residues served as an "linker-arm" onto which the rest of the peptide was 
synthesised. Gly was chosen because of its basic structure and ease of coupling. The C-
terminal of the ILK peptides was attached to this (GlY)3-linker. 
Omitting the N-terminal dipeptide unit Tyr-Lys from the 18-residue peptide, formed the 16-
residue peptide. The omission of the next N-terminal dipeptide unit, Leu-Leu, formed the 14-
residue peptide. The 12-residue peptide was formed by omission of Leu and Lys. The 18-
residue peptide has five Lys residues, and therefore net five positive charges, whereas the 12 
residue only has three Lys residues. Both the 14-residue and the 16-residue peptides have four 
Lys residues, but they differ in that the 14-residue peptide have two Leu residues less, and 
therefore a smaller hydrophobic face (see Table 3.1). 
From the assumption that these peptides are all a-helical [2, 8], 3-dimensional structures were 
generated with HyperChem® 4.5 (Fig. 3.1). It can be seen that a "cavity" at the hydrophilic 
face widens and the "density" of the hydrophobic face decreases with peptide length (Fig. 
3.1). In the helical wheel representations of the four peptides (Fig. 3.2) the changes in the 
hydrophobic face and hydrophilic face can be seen as peptide length decreases. 
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NLK12 
NLK14 
Figure 3.1 An amino- to carboxy-terminal view of the a-helical structures of the model 
peptides NLK 12, NLK 14, NLK 16 and NLK 18. The structures were generated 
with HyperChem® 4.5 [11]. (The dark blue lines depict the amino groups, red 
the oxygen containing groups, light blue the carbon atoms and green the 
hydrogen atoms.) 
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Figure 3.2 Helical wheel representation of the peptides of the a-helical structures of the 
model peptides NLK12, NLK14, NLK16 and NLK18. (The blue circles 
represent the polar charged groups, the green circles the uncharged polar groups, 
and the grey circles the non-polar groups.) 
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Peptide 
name 
ILK12 
ILK14 
ILK16 
ILK18 
LK12 
LK14 
LK16 
NLK18 
3.6 
List of the cationic a-helical model peptide analogues synthesised in this 
study, showing the primary structure, net charge and number of amino acids in 
the hydrophobic face (H0 face). (® depicts the Pepsyn K-NH(CH2)2 H-resin). 
Number of Net H 0 
Peptide primary structure amino acids charge face 
LLPKLKGLLFKLGGG-® 12+(GlY)3 3+ 6 
KLLLPKLKGLLFKLGGG-® 14+(GlY)3 4+ 6 
LLKLLLPKLKGLLFKLGGG-® 16+(GlY)3 4+ 8 
YKLLKLLLPKLKGLLFKLGGG-® 18+(GlY)3 5+ 8 
LLPKLKGLLFKL-NH2 12 3+ 6 
KLLLPKLKGLLFKL-NH2 14 4+ 6 
LLKLLLPKLKGLLFKL-NH2 16 4+ 8 
YKLLKLLLPKLKGLLFKL-NH2 18 5+ 8 
The antimicrobial tests of the free peptide amides were done usmg the gram-positive 
bacterium, J\1. llifelis and the gram-negative bacterium, E. coli. These antimicrobial tests were 
done using only one strain each of M Ill feus and E. coli. Peptide toxicity was tested against 
rabbit red blood cells . The activity of the immobilised peptides was tested against M lufells . 
3.2 Materials 
Micrococcus lufells (NCTC 8340) and Escherichia coli (HB 1 0 1) were used as indicator 
organisms in the antimicrobial activity experiments. Microtiter plates (Nunc-Immuno'" 
Maxisorp) were from Nalge NUNC International (Roskilde, Demnark), Falcon® tubes from 
Becton Dickinson Labware (Lincon Park, USA) and culture dishes from Quality Scientific 
Plastics, USA. Low-electroendosmosis-type agarose (D 1-LE) was from Whitehead Scientific 
(Brackenfell, South Africa). Tween was from Fluka (Buchs, Switzerland). Dulbecco 's 
phosphate buffered saline (PBS)I was either from Life Technologies (Faisley, Scotland), or 
prepared in the laboratory [12]. Sodium chloride was from Saarchem (Krugersdorp, South 
10.2% potass ium dihydrogen phosphate, 0.115% disodium hydrogen phosphate, 0.02% potassium chloride, 0.8% 
sod ium chloride (m/v), pH 7.2 
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Africa). Disodium hydrogen phosphate and citric acid were from Merck (Darmstadt, 
Germany). Potassium chloride, potassium dihydrogen phosphate, tryptone soy broth (TSBi 
and casein were from Merck (Midrand, South Africa). D-glucose was from BDH Chemicals 
Ltd. (Poole, England). Trisodium citrate was from B&M Scientific cc. (Cape Town, South 
Africa). Melittin was from Sigma-Aldrich Chemie (Steinheim, Germany). Analytical quality 
water was prepared by filtering glass distilled water through a Millipore Milli Q® water 
purification system. HV 0.45 micron membrane filters were from Waters-Millipore (Milford, 
USA). 
3.3 Methods 
3.3.1 Peptide synthesis and purification 
Peptides were synthesised at room temperature according to the Fmoc-polyamide protocol 
using the shake flask procedure (refer to Chapter 2, sections 2.3.3.4 and 2.3.3.5). The crude 
NLK peptides were purified using gel permeation chromatography (section 2.3.4.1). Further 
purification on NLK12 was by means of semi-preparative reverse phase high pressure liquid 
chromatography (HPLC) using a semi-preparative CIS Polygosil column (irregular particle 
size, 60A pore size, 250 mm x 10 mm) as described in Chapter 2, section 2.3.4.3. The ILK 
peptides were not purified, because the peptide was irreversibly coupled to the resin after 
synthesis. However, special care was taken during the synthesis procedure to ensure a high 
purity peptide (section 2.3.3.1). 
3.3.2 Preparation of cells 
All experiments using bacteria, involved standard sterile teclmiques used in microbiology. A 
starter culture of the bacteria that was used as target cells was grown overnight, at 37°C, in a 
nutrient-rich medium (tryptone soy broth, TSB2). This overnight culture was inoculated into 
fresh TSB and grown until the mid-log phase as determined by optical density (OD) 
measurements (0.6 at 620 nm). For the micro-gel well diffusion assay ([13], section 3.3.3) the 
2 1.17% tryptone, 0.3% soy peptone, 0.5% sodium chloride, 0.25% di-sodium hydrogen phosphate, 0.25% 
dextrose (m/v), pH = 7.3 
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cells were centrifuged at 900g for 10 min. The supernatant was discarded and the cells 
were washed once with 10 mL cold Dulbecco's PBS 1 by centrifugation. Finally, the cells 
were diluted to an OD of 0.6 in Dulbecco's PBS. For the immobilised peptide assay (section 
3.3.5) the cells were diluted with TSB to the desired concentration of 105 cells per mL (from 
OD620 0.2 = 5 XI07 cells, [14]). 
3.3.3 Micro-gel well diffusion assaying of the free peptide amides [13J 
Peptides were filtered through HV 0.45 ~lm Millipore filters a day prior to performing an 
assay and freeze-dried overnight to remove any insoluble particles. The dried filtered peptide 
preparations were weighed using a Sartorius analytical scale. Peptide dilutions were made 
from a stock solution (1 mg/mL in 50% acetonitrile/analytical grade water) just before 
performing an assay. 
The ICso (peptide concentration leading to 50% inhibition of microbial grow1h) of each 
peptide was determined by performing two dose response experiments. Eight dilutions of each 
peptide were prepared and microbial growth of quadruplicate determinations per peptide 
concentration was recorded. 
The micro-gel well diffusion assay was performed according to a previously described 
method [13]. Microtiter plates were blocked with 0.5% casein in Dulbecco's PBS for one 
hour and sterilised under UV light for a further four hours. A gel solution containing 1 % 
(m/v) of powdered TSB medium, 1 % (m/v) of low-electroendosmosis-type agarose, and 
0.02% (m/v) Tween 20 made up in Dulbecco's PBS, was prepared and autoclaved. The gel 
solution was used at 45± 1°C and therefore kept in a water bath at 46± 1 dc. The first column of 
the microtiter plate received 70 pL of gel, to serve as blank and sterility control. Into each of 
the other wells, 70 pL of a bacterial-gel suspension, prepared by mixing 70 pL bacteria and 
700 pL gel, was applied. The suspension was prepared for each column immediately before 
application. Once the desired number of wells was prepared, the gel was allowed to set for 
one hour. Hereafter the test sample was applied directly to the gel in the wells, bringing the 
total volume in the well to 100pL. The microtiter plate was covered and incubated for 17 
hours at 37°C. The light dispersion per well was determined using a Multiscan Titertec 
microtiter reader at 62011m. 
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3.3.4 Haemolysis assays 
The haemolytic activities of the free peptide amides were determined by using rabbit red 
blood cells (RBC). Blood was drawn from the rabbit into an equal amount of Alsever's 
solution (2.05% glucose, 0.80% sodium citrate, 0.42% sodium chloride and 0.055% citric 
acid, m/v, pH between 7.2 and 7.3). The blood was kept at 4°C at least a week to ensure 
plasma and erythrocyte separation and RBC stabilisation. During this week the plasma and 
other cells were removed by suction and Alsever's solution again added to the erythrocytes. 
The Alsever's solution was removed by centrifugation (900 g for 10 minutes) just prior to the 
assays. The cells were then washed three times with 0.15 M phosphate buffered saline (PBS, 
0.02% potassium dihydrogen phosphate, 0.115% disodium hydrogen phosphate, 0.02% 
potassium chloride, 0.8% sodium chloride (w/v), pH 7.2) and then finally resuspended in 
PBS. Peptides, dissolved in 50% acetonitrile/analytical water, were added to 1 00 ~L of the 
RBC (2.5 x 108 cells/mL) and 800 ~lL PBS to reach a final volume of 1.0 mL. The peptide 
stock solutions were prepared as described in section 3.3.3. Following gentle mixing, the 
peptide-RBC suspension was incubated for 30 minutes at 37°C. Samples were then 
centrifuged for 5 minutes on a bench centrifuge (small type micro centrifuge). Hundred ~L of 
the supernatants were aliquoted (in duplicate) into a microtitre plate and the absorbance 
measured at 405 nm with a Multiscan Titertec microtiter reader. Background haemolysis was 
determined by incubation of the rabbit red blood cells in PBS with 50% acetonitrile/analytical 
water. Complete haemolysis of the rabbit red blood cells in PBS was determined with 100 
~g/mL melittin dissolved in 50% acetonitrile/analytical water. 
The HCso (peptide concentration leading to 50% haemolysis) of each peptide was determined 
by performing two dose response experiments. Six dilutions of each peptide were prepared 
and haemolysis of quadruplicate determinations per peptide concentration were recorded. 
3.3.6 Antibacterial assaying of the immobilised peptides 
The peptide-resin (ILK) was fine-ground in a pestle and mortar to increase the exposure of the 
insoluble peptide to the microorganisms. The peptide-containing resin was autoclaved before 
use. The insoluble peptide-resin conjugates \vere evaluated at concentrations of 1 ~lmole/mL 
and 3 ~lmole/mL respectively (the amount of peptide-resin ranged from 10 to 40 mg/mL). 
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The reaction vessels (plastic Eppendorf tubes) containing the peptide-resin were 
inoculated with cells in growth medium so that the cell concentration was 10s cells/mL. The 
reaction volume was 0.2 mL and the cell-resin suspensions were incubated at 37°C with 
gentle shaking (-250 rpm). 
After 17 hours, each suspension was mixed and transferred into a sterile Eppendorf tube. The 
resin was removed by filtering the suspension through a 1 mL sterile plastic syringe 
containing the cotton wool plug (15 mg). The cotton wool plug kept the resin back and only 
let the cells through. TSB (200 ).iL) was used to wash the syringe and also transferred through 
the syringe into the Eppendorf tube. Two 100).iL aliquots each of the filtered suspensions 
were pipetted into a microtiter plate and light dispersion at 620 nm was determined using a 
Multiscan Titertec microtiter plate reader. Cells incubated with resin containing no peptide 
were used to determine 100% growth. 
3.3.5 Data Processing 
All data was analysed using Graphpad Prism version 2.01 for Windows, GraphPad Software, 
San Diego California USA (www.graphpad.com). Nonlinear regression \vas performed on the 
dose-response data obtained from the micro-gel well diffusion assays and the haemolysis 
assays. A sigmoidal curve with variable slope and constant top of 100 and bottom of 0 was 
fitted to each of the data sets. The 50% inhibition of microbial growth (ICso) and the 50% 
haemolysis of RBS (HCso) were deduced from the following equation: 
Y = 100/(1 + 1 O(log IC:lUx FIlii slope) where: 
log ICso (or log HCso) = X-value of response halfway between top and bottom 
Hill slope = Hill coefficient (describes the steepness of the curve) 
For the NLK-peptides, two experiments in quadruplicate were performed with each peptide 
against each target cell. The ICso/HCso obtained from the two experiments were analysed 
using Tukey's Multiple Comparison Test in GraphPad Prism 2.01 to ascertain if the observed 
differences were significant. 
For the ILK peptides, four experiments in quadruplicate were performed with each peptide 
against Ai !ufeus. The % gro\vth inhibition of each of the peptides was tested at two peptide 
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concentrations. The data obtained from the four experiments were analysed usmg 
Tukey's Multiple Comparison Test in GraphPad Prism 2.01 to ascertain if the observed 
differences were significant. 
3.4 Results and Discussion 
3.4.1 Biological activity of the NLK peptide amides 
The influence of N-terminal deletion of dipeptide units from the original 18-residue peptide 
amide (NHr YKLKLLKLLLPKLKGLLFKL), identified by Blondelle et al. [8], on biological 
activity was ascertained by using M lute us, E. coli and rabbit erythrocytes as target cells. 
The ICso values for the four NLK peptides with A1. luteus as target cell were determined using 
the micro-gel well diffusion assay (Fig 3.3, Table 3.2). Although the hexadecapeptide 
(NLK 16) showed the highest activity against M luteus over a broad concentration range (Fig. 
3.3), its ICso value was not significantly different (P > 0.05) from that of original 
octadecapeptide (NLKI8) (Table 3.3). There was, however, a significant difference between 
the ICso values obtained for these two longer peptides and NLK14 (P < 0.05). NLK14 showed 
a higher ICso (21.9 ± 4.9 nmole/mL) and thus a lower activity than NLK18 (ICso = 6.0 ± 0.7 
nmole/mL) and NLK16 (lCso = 3.6 ± 0.3 mnole/mL). After repetitive attempts, the ICso of 
NLK12 could not be determined. The initial experiments, with the peptide dissolved in 50% 
acetonitrile/water, gave ambiguous results. In later experiments, with the peptide dissolved in 
water, aggregation at high concentrations was observed. From these experiments ICso of 
> 100 nmole/mL was calculated. 
The micro-gel well diffusion assay was again used to determine the ICso values of the four 
NLK peptide amides with E: coli as target cell (Fig 3.4, Table 3.2). The octadecapeptide, 
NLK18, was the most active over a broad concentration range (Fig. 3.4). There was, however, 
no significant difference (P > 0.05) between the IC50 of NLK18 (13.9 ± 1.9 nmole/mL) 
and NLK16 (21.6 ± 2.0 nmole/mL). Both these peptides had significantly (Table 3.3) lower 
ICso values than thatofNLK 14 (31.4 ± 0.2 nmole/mL). Because of the aggregation, the ICso 
of NLK12 against E. coli could not be determined. NKL12 activity (ICso > 100 nmole/mL) 
was again compromised by self-aggregation in solution. 
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Figure 3.3 Sigmoidal dose-response curves of the NLK peptides with M luteus as target 
cell. The combined data of two experiments are shown with standard error of the 
mean (SEM) for each concentration value. 
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Figure 3.4 Sigmoidal dose-response curves of the NLK peptides with E. coli as target cell. 
The combined data of two experiments are shown with SEM for each 
concentration value . 
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A similar dose response effect was observed in the peptide activity against red blood cells 
(Fig 3.5). Overall the octadecapeptide was more haemolytic than the other peptides. There 
was, however, no significant difference (P > 0.05) between the HCso values of this 
octadecapetide, NLK18 (3.7 ± 0.7 nmole/mL), and LK16 (5.2 ± 0.4 nmole/mL) . Their 
activity however, was higher than that of NLK14, whose HCso (14.6 ± 2.3 mTIole/mL) 
differed significantly from both (P < 0.05). Aggregation was observed for LK12 and could 
again be the reason why the haemolytic activity of tllis peptide was negligible (HC50 > 1 00 
nmole/mL). 
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Figure 3.5 Sigmoidal dose-response curves of the NLK peptides with rabbit red blood cells 
as target cell. The combined data of two experiments are shown with SEM for 
each concentration value. 
Table 3.2 Summary of the ICso values obtained with M lute us (NCTC 8340) and E. coli 
(HB 1 01) as target cells and the HCso values with rabbit red blood cells as target 
cells. Values are the average of two experiments ± SEM. 
Peptide ICso ± SEM against ICso ± SEM against HCso ± SEM against 
M. {litelis (nmole/mL) E. coli (nmole/mL) RBC (nmole/mL) 
NLK18 6.0 ± 0.7 13.9 ± 1.9 3.7 ± 0.7 
NLK16 3.6 ± 0.3 2l.6 ± 2.0 5.2 ± 0.4 
LK14 21.9±4.9 31.4 ± 0.2 14.6 ± 2.3 
KL12 > 100 > 100 > 100 
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Table 3.3 Significance of differences in peptide activity (IC50/HC50) as determined 
with Tukey ' s Multiple Comparison Test. 
Significance of difference in peptide activity 
Comparison M. lutells growth E. coli growth Rabbit RBC 
inhibition inhibition haemolysis 
P > 0.05 P > 0.05 P > 0.05 
NLK18 vs. NLK16 
Not significant Not significant Not significant 
P < 0.05 P < 0.01 P < 0.05 
NLK18 vs. NLK14 
Significant Highly significant Significant 
P < 0.05 P < 0.05 P < 0.05 
NLK16 vs. NLK14 
Significant Significant Significant 
3.4.2 Antimicrobial activity of the ILK peptides against M. lute us 
3.14 
Inhibition of the growth of 1\1. lutells of each of the immobilised peptides was tested at two 
peptide concentrations, namely l~lmole/mL and 3~lmole/mL (Table 3.3). Only two 
concentrations were chosen because of limited amounts of peptide. The highest activity of the 
free peptide amides was against 1\1. /lIfells and thus it was decided to test the influence of 
immobilisation on biological activity against these target cells. The two peptide 
concentrations were chosen from the results given by Haynie et al [9]. In preliminary tests, 
using lower peptide concentrations, it was observed that the target cells adheres to the 
peptide-resin. The peptide-resin became yellow when incubated with M lu/eus. This was not 
observed with the resin containing no peptide. After multiple washings, the yellow colour, 
and therefore the target cells, could not be removed from the peptide-resin. Therefore there 
was interaction between the peptide and the bacterium, but not high enough to result in the 
inhibition of growth. It seems as if the chosen peptide concentrations (1 ~llnole/mL and 
3~mole/mL ) were too low, because growth inhibition > 55% was only observed for one of 
the peptides, ILK16 (Table 3.3) . Therefore it could be suggested that higher peptide 
concentrations be used. In tlus case, however, the resin volume could be a problem, because 
all the resin (and peptide) would not be in contact with the target cells and therefore the 
correct peptide concentration vlould not be known. 
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As with activity on M luteus of the free peptides, the highest activity was again observed 
for the hexadecapeptide. Tukey's Multiple Comparison Test confirmed that the activity of 
ILK16 was significantly different (P < 0.05) from the activity of the other ILK-peptides. This 
peptide in its immobilised form (ILK16) inhibited 77% of bacterial growth (shaded cell in 
Table 3.4) at a concentration of 3 flmole/mL. The activity was about a 1000 fold less than this 
free peptides' (NLKI6) activity on M luteus (Table 3.2). ILKI2, at both concentrations, gave 
the lowest activity of all the ILK peptides against M luteus. This result substantiates the 
previous observation that this free peptide (NKL12) was virtually devoid of antibacterial and 
haemolytic activity. 
Table 3.4 Percentage growth inhibition of the ILK peptides against M luteus. Values are 
the average of 16 measurements ± SEM. 
% growth inhibition ± SEM 
Immobilised 1 flmollmL peptide 3 flmol/mL peptide 
Peptide 
ILK18 37.9 ± 4.1 49.2 ± 2.2 
ILK16 52.7 ± 6.6 77.3 ± 3.7 
ILK14 51.9 ± 4.0 43.1 ± 4.5 
ILK12 26.9 ± 4.8 22.4 ± 4.1 
3.5 Conclusions 
NLK12 was devoid of antibacterial and haemolytic activity over the concentration range of 
10-100 nmol/mL. The three longer NLK peptides had substantial antibacterial activity, but 
were more active towards the gram-positive bacterium, M luteus, than towards the gram-
negative bacterium, E. coli. This specificity could be attributed to the difference in membrane 
structure of these two organisms, with E. coli having a thicker membrane because of its 
lipopolysaccharide layer. This result was however, the opposite of what was observed with 
the natural occurring peptides magainin and cecropin, which were more active against the 
gram-negative than the gram-positive organisms [15]. The difference in activity between the 
model peptides and the natural occurring peptides could be attributed to peptide sequence and 
peptide length. The model peptides consisted only of 18, or less, amino acids (mostly Lys and 
Leu) while the natural peptides consist of more aminoacids. However, both the natural and the 
model peptides form amphipathic a -helices and are cationic in nature. Interestingly, with 
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1\1. luteus as target cells, the HC sD values of the peptides were in the same range than that 
of the ICsD values. The haemolytic activity of these model peptides thus somehow correlated 
with their activity against gram-positive organisms. 
Similar activities were observed for NLK18 and NLK16 when tested against the same 
organism. However, the hexadecapeptide, NLK 16, was more than five fold less active against 
E. coli than M luteus, while the other two peptides were about two fold less active. The 
difference in activity is accounted for by NLK16 having one less positive charge than NLK18. 
NLK 14 was less active than the two longer peptides. The activity of NLK 14 was therefore 
p 
influenced by peptide length (it is shorter than the other 2 peptides) and the size of the 
hydrophobic face (it has two less Leu residues). The 12 residue peptide was devoid of 
antimicrobial activity in solution, but retained surface activity in the immobilised form. 
Having only a net positive charge of three, the peptides tend to self-aggregate in solution 
because there is less charge repulsion. Aggregation was restricted in the immobilised form 
and therefore surface activity could be observed. 
Thus, peptide length is not such a crucial parameter in activity against 1\1. lute us and RBC as 
activity probably depends on membrane thickness. The size of the hydrophobic face is very 
important for activity against all the organisms. The charge of the hydrophilic face is probably 
only important in activity against E coli. 
The differences in activity that were observed between the different NLK peptides can 
therefore be related to peptide length, charge and the amphipathic helix (hydrophilic versus 
hydrophobic faces). 
The immobilised peptides were about or more than 1000 fold less active against A1 l/lleus 
than their free amide counterparts. The structural constraint caused by the resin therefore 
restricted the activity of the peptides on the target cells to surface activity. The lowest activity 
was also observed for the 12' residue peptide, but the fact that this immobilised peptide was 
slightly active imply that it still retained some surface activity. 
3.6 References 
1. Bessalle, R., Gorea, A., Shalit, I., Metzger, J. W., Dass, C., Desiderio, D. M. & Fridken, 
M. (1993) J j\1ed. Chem. 36, 1203-1209 
Stellenbosch University  https://scholar.sun.ac.za
3.17 
2. Blondelle, S. E. & Houghten, R. A. (1992) Biochemistry 31,12688-12694 
3. Cornut, I., Buttner, K., Dasseux, J-L. & Dufourcq, 1. (1994) FEBS Letters 349,29-33 
4. Anzai, K., Hamasuna, M., Kadono, H., Lee, S., Aoyagi, H. & Kirino, Y. (1991) Biochim. 
Biophys. Acta. 1064,256-266 
5. McLean, L.R., Hagaman, K.A., Owen, T.1. & Krstenansky, l.L. (1991) Biochemistry 30, 
31-37 
6. Mishra, V. K.& Palgunachari, M. N. (1996) Biochemistry 35,11210-11220 
7. Segrest, J. P., De Loof, H., Dohlman, 1.G., Brouillette, C.G.A. & Anantharamaiah, G. M. 
(1990) Proteins 8, 108-117 
8. Kamal, G. D. (1991) lAMA 265, 2364-2368 
9. Haynie, S. L., Crum, G.A. & Doe1e, B. A. (1995) Antil11icrob. Agents Chemotherapy. 39, 
301-307 
10. Blondelle, S. E., Takahashi, E., Houghten, R. A. & Perez-Paya, E. (1996) Biochem J 313, 
141-147 
11. Hyperchem WWW site: http\\www.hyper.com 
12. Dulbecco, R. & Vogt, M. (1954) J Exp. J\1ed. 98,167 
13. Du Toit, E. A. & Rautenbach, M (1998) A sensitive micro-assay for the determination of 
antimicrobial activity, Biochemistry in Africa, Second F ASBMB and Fifthteenth 
SASBMB joined congress, Potchefstroom, North-Western Province, South Africa 
14. Lehrer, R. I., Rosenman, M., Harwig, S. S. S. L., Jackson, R. & Eisenhauer, P. (1991) J 
lmmunol. Methods 137,167-173 
15. Tytier, E. M., Anantharamaiah, G. M., Walker, D. E., Mishra, V. K., Palgunachari, M. N. 
& Segrest, J. P. (1995) Biochemistry 34,4393-4401 
Stellenbosch University  https://scholar.sun.ac.za
4.1 
Chapter 4 
Conclusions 
The world of antimicrobial peptides is a complex puzzle with many missing pieces. Over the 
years many parts of the puzzle have been completed, but still researchers continue the quest to 
find out exactly how these peptides work (refer to Chapter 1). 
The aim of this study was to examine the structure-function relationship of a model antimicrobial 
peptide. Blondelle et af. [1] identified, using combinatorial libraries, a model KL-peptide with 
10-fold enhanced antimicrobial activity when compared to the original KL-peptide [2]. 
Synthesising this peptide and three N-terminal deletion analogues in both the free peptide amide 
and the immobilised form, allowed us to test the influence of peptide length, charge, size of the 
hydrophobic face vs. the hydrophilic face and immobilisation on their biological activity. 
Peptides were synthesised at room temperature according to the Fmoc-polyamide protocol using 
the shake flask procedure (refer to Chapter 2, sections 2.3.3.4 and 2.3.3.5). For the immobilised 
peptides, one synthesis was done on the ethylene modified water-insoluble resin, 
polydiacrylamide in Kieselguhr (Pepsyn K), as described by Haynie et al [3]. During the 
synthesis of the ILK-peptides the average coupling efficiency was between 98 and 99%. Great 
care was taken to ensure maxil11unl coupling, because these peptides remained iml110bilised to the 
resin and could thus not be purified. The free peptide amides were synthesised on a resin from 
which the peptide ami des were liberated by either l11ethanolic ammonia or liquid ammonia. The 
use of methanolic ammonia to liberate the 12-residue peptide, NLKI2, lead to the formation of 
methyl esters as well as correct peptide amides. These two peptides were extremely difficult to 
separate from each other (section 2.4.4.1). The number of purification steps, necessitated by the 
presence of this contaminating peptide methyl esters, greatly decreased the overall peptide amide 
yield. Therefore, NLK 12 was synthesised again to ensure a sufficient amount of peptide to 
perform the biological activity experiments. The longer resin-bound peptides were successfully 
liberated as peptide al11ides by liquid ammonia treatment. By using this method, however, all the 
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peptide was not removed from the reS1l1 and a second treatment with liquid ammOl1la was 
necessary. Some of the resins still contain peptide and complete liberation will necessitate more 
liquid ammonia treatments (Table 2.6). In using liquid ammonia, purer peptides were liberated, as 
shown by ES-MS (section 2.4.5.1). These peptides were further purified using gel permeation 
chromatography to remove residual contaminating material. One of the reasons for the relatively 
low purified peptide yield (44-62%) could be because of increased aggregation when the peptides 
are in the pure form. This aggregration was observed with analytical HPLC for all the peptides 
(section 2.4.5.2). During HPLC, the high concentrations of peptide needed for visualisation (the 
shorter peptides did not contain any UV-absorbing residues) aggravated the problem of 
aggregation. 
In performing the antimicrobial assays with the free peptide amides, the biggest problem again 
proved to be the tendency of the peptide to aggregate. Although peptide preparations were made 
just prior to performing the dose response experiments, the ICso and HCso of the 12-residue 
peptide could not be successfully determined (section 3.4.1). Having only a net positive charge of 
three, instead of five as in the IS-residue peptide, this peptides' tendency to self-aggregate is 
probably because it has less charge repulsion than its longer analogues. This resulted in the 
peptide exhibiting ICso values and a HCso of greater than 100 nmole/mL. 
Peptide length is not the only factor influencing antimicrobial activity in the NLK-peptides, 
although the 12-residue peptide showed the lowest activity. Deletion of amino acids from the N-
terminal changed the net charge and the balans between the hydrophobic and hydrophilic face of 
the shorter peptides. It was, however, observed that the two longer peptides (NLK 16 and NLK 
IS) had almost similar activities, while the two shorter peptides (NLK 12 and NLK 14) were less 
active. It was shown that a minimum peptide length of IS residues is therefore not always 
necessary for antimicrobial activity. In other studies, [4, 5] it was observed that peptides with as 
little as eight residues still had antimicrobial activity. 
The three longer NLK peptides (NLK IS, NLK 16 and NLK 14) had substantial antibacterial 
activity (Table 3.2), but were more active towards the gram-positive bacterium, M lufeus, than 
to\-vards the gram-negative bacterium, E. coli. This specificity could be attributed to the 
difference in membrane structure of these two organisms, vvith E. coli having a more complex 
membrane because of its lipopolysaccharide layer. This result, however, was the opposite of what 
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was observed for the naturally occurring peptides magainin and cecropin [6], which are more 
active against gram-negative than gram-positive organisms. The difference in activity between 
these model peptides and the naturally occurring peptides could be attributed purely to amino 
acid sequence. Our model peptides consisted mostly of Lys and Leu amino acids, while the 
natural peptides consist of a more diverse range of amino acids. However, both the natural and 
the model peptides form amphipathic a-helixes and are cationic in nature. Our peptides were 
only tested against one strain each of M lute us and E.coli. It should have been tested against 
more than one strain because mutations can occur and give different results. 
Taking the diversity of natural peptides into account, Tossi et al. [7] designed a peptide 
consisting of the amino acids which occur most frequently in the first 20 positions of natural 
occurring peptides. In the hydrophobic face the aliphatic, hydrophobic residues dominates, while 
the hydrophilic face is considerably more variable. The hydrophobic face in their designed 
peptides consists of contiguous hydrophobic residues, whereas the hydrophilic face consists of 
hydrophilic residues interspersed with hydrophobic residues. The importance of the number of 
the contiguous residues in the hydrophilic face of antimicrobial peptides to have antimicrobial 
activity, have been shown by Blondelle ef a/ [2]. They confirmed that a hydrophobic presenting 
face of five contiguous residues is sufficient for the peptide to interact with the bacterial cell wall. 
In our 18-rcsidue and the 16-residue peplides the hydrophobic face has eight contiguous residues. 
The six contiguous residues in hydrophobic faces of NLKI4 and NLKI2 were clearly not 
sufficient to maintain biological activity. They have two Leu residues less than NLK 16 and 
NLK 18, which indicates that the density of the hydrophobic face also influences the peptides 
antimicrobial activity. 
Bessalle et al. [8] showed that the relative proportion between the number of hydrophobic and 
basic residues of the peptide is also very important for activity. In order to achieve high 
bioactivity, 30%-45% of the amino acid residues should be basic, whereas the rest can be 
hydrophobic. The peptides used in this study have between 25% and 28% basic residues. The 
activity of NLKI8 was statistically (P > 0.05) similar to that NLKI6 when tested against the 
same organism. However, the hexadecapeptide, NLK 16, was more than five-fold less active 
against E. coli than M luteus, while the other two peptides (NLKI8 and NKLI4) were about two-
fold less active. NLK16 has one positive charge less when compared to NLKI8, which seems to 
be the contributing factor in the lower activity of the 16-residue peptide against E. coli. It also 
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seems as if this single charge difference of NLK16 has a greater influence on activity against the 
gram-negative bacteria than against the gram-positive bacteria. Although the NKL 16 and NKL 14 
both have a net positive charge of four, they have different activities. The reduced length of 
NLK14 and change in amphiphilic balance must therefore be responsible for its lower activity. 
From these studies it can be seen that is not one single characteristic that influences the activity of 
the peptides, but a combination of the correct peptide length, positive charge and size of the 
hydrophilic vs. hydrophobic faces (refer to Chapter 3). Our results correlated with those reported 
by Oh et al. [9]. They showed, using short « I8-residues) antimicrobial peptides, that a high 
value in some structural parameters (net charge, hydrophobicity and a-helicity) is not enough for 
the best antimicrobial activity, but that an optimal balance in structural parameters, particularly 
amphipathic balance, is required. 
The biggest constraint in examining the antimicrobial activities of these immobilised peptides 
was that only a limited amount of peptide could be used. The insoluble resin support on which 
the peptides were immobilised did not lend itself to an simple way of assaying the peptides' 
purity or antimicrobial activities. If the amount of resin becomes to high, all the resin particles, 
and therefore the peptide, would not be in contact with the target cells and the active 
concentration of peptide would be unknown. Form these experiments we, however, were able to 
show that the immobilised peptides were about or more than 1000 fold less active against M 
luteus than their free amide counterparts. The structural constraint caused by the resin therefore 
restricted the activity of the peptides on the target cells to surface activity. The highest activity 
was also observed for the 16-residue peptide, ILK16 (Table 3.4). The lowest activity was again 
observed for the 12-residue peptide, but the fact that this immobilised peptide was slightly active 
implies that it still retained some surface or membrane activity. In the immobilised form, self-
aggregation was probably restricted and thus some activity was retained. For all the immobilised 
peptides it was found that they tend to very tightly to bind to M iuteus as we unable to 
reconstitute activity and remove the characteristic yellow of M lute us form the resin particles 
after incubation. 
If a higher antimicrobial activity could be obtained with the immobilised peptides, a vast array of 
applications could be found. In future studies we are planning to immobilise these peptides and 
other more active peptides in different ways (e.g. using longer linkers or labile linkers) and to 
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different in order to improve the eventual antimicrobial activity. An improvement in activity 
could possibly be obtained by immobilising the peptide onto a different more exposed support. 
Different types of porous membranes with large exposed surface areas would be feasible options 
as matrixes for immobilisation. Immobilisation onto these supports would create an antimicrobial 
surface that could be applied in water purification to decrease the number of bacteria. If 
immobilised to paper or plastic, the antimicrobial peptides could help extend the fruit ripening 
process and it could help in keeping fruit fresh for longer. Thus, immobilised antimicrobial 
peptide could form part of our daily lives, just like their natural analogues do. 
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